<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:15:35Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9772259" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9772259</identifier>
        <datestamp>2022-12-23</datestamp>
        <setSpec>frontimmu</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
              <journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
              <journal-title-group>
                <journal-title>Frontiers in Immunology</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1664-3224</issn>
              <publisher>
                <publisher-name>Frontiers Media S.A.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9772259</article-id>
              <article-id pub-id-type="pmcid">PMC9772259</article-id>
              <article-id pub-id-type="pmc-uid">9772259</article-id>
              <article-id pub-id-type="pmid">36569939</article-id>
              <article-id pub-id-type="doi">10.3389/fimmu.2022.1016165</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Immunology</subject>
                  <subj-group>
                    <subject>Original Research</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Integrative transcriptomic analysis in human and mouse model of anaphylaxis identifies gene signatures associated with cell movement, migration and neuroinflammatory signalling</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Rijavec</surname>
                    <given-names>Matija</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="fn001" ref-type="author-notes">
                    <sup>*</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/1598816"/>
                  <xref rid="fn003" ref-type="author-notes">
                    <sup>†</sup>
                  </xref>
                  <xref rid="fn004" ref-type="author-notes">
                    <sup>‡</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Maver</surname>
                    <given-names>Aleš</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <xref rid="fn003" ref-type="author-notes">
                    <sup>†</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/666432"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Turner</surname>
                    <given-names>Paul J.</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/988347"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hočevar</surname>
                    <given-names>Keli</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/615715"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Košnik</surname>
                    <given-names>Mitja</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/950240"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yamani</surname>
                    <given-names>Amnah</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                  <xref rid="aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hogan</surname>
                    <given-names>Simon P.</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                  <xref rid="aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Custovic</surname>
                    <given-names>Adnan</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/364144"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Peterlin</surname>
                    <given-names>Borut</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/46209"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Korošec</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff8" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                  <uri xlink:href="https://loop.frontiersin.org/people/705254"/>
                </contrib>
              </contrib-group>
              <aff id="aff1"><sup>1</sup><institution>University Clinic of Respiratory and Allergic Diseases Golnik</institution>, <addr-line>Golnik</addr-line>, <country>Slovenia</country></aff>
              <aff id="aff2"><sup>2</sup><institution>Biotechnical Faculty, University of Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country>Slovenia</country></aff>
              <aff id="aff3"><sup>3</sup><institution>Clinical Institute of Medical Genetics, University Medical Centre</institution>, <addr-line>Ljubljana</addr-line>, <country>Slovenia</country></aff>
              <aff id="aff4"><sup>4</sup><institution>National Heart and Lung Institute, Imperial College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country></aff>
              <aff id="aff5"><sup>5</sup><institution>Medical Faculty, University of Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country>Slovenia</country></aff>
              <aff id="aff6"><sup>6</sup><institution>Department of Pathology, Michigan Medicine, University of Michigan</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country></aff>
              <aff id="aff7"><sup>7</sup><institution>Mary H. Weiser Food Allergy Center (MHWFAC), Department of Pathology, Michigan Medicine, University of Michigan</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>United States</country></aff>
              <aff id="aff8"><sup>8</sup><institution>Faculty of Pharmacy, University of Ljubljana</institution>, <addr-line>Ljubljana</addr-line>, <country>Slovenia</country></aff>
              <author-notes>
                <fn fn-type="edited-by">
                  <p>Edited by: Philipp Starkl, Medical University of Vienna, Austria</p>
                </fn>
                <fn fn-type="edited-by">
                  <p>Reviewed by: Jelle Folkerts, Erasmus Medical Center, Netherlands; Adrian Piliponsky, Seattle Children’s Research Institute, United States</p>
                </fn>
                <corresp id="fn001">*Correspondence: Matija Rijavec, <email xlink:href="mailto:matija.rijavec@klinika-golnik.si">matija.rijavec@klinika-golnik.si</email>
</corresp>
                <fn fn-type="equal" id="fn003">
                  <p>†These authors have contributed equally to this work and share first authorship</p>
                </fn>
                <fn fn-type="other" id="fn004">
                  <p>‡ORCID: Matija Rijavec, <uri xlink:href="https://orcid.org/0000-0002-2596-4952">orcid.org/0000-0002-2596-4952</uri>
</p>
                </fn>
                <fn fn-type="other" id="fn002">
                  <p>This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>08</day>
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>13</volume>
              <elocation-id>1016165</elocation-id>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>10</day>
                  <month>11</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2022 Rijavec, Maver, Turner, Hočevar, Košnik, Yamani, Hogan, Custovic, Peterlin and Korošec</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Rijavec, Maver, Turner, Hočevar, Košnik, Yamani, Hogan, Custovic, Peterlin and Korošec</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
                </license>
              </permissions>
              <abstract>
                <sec>
                  <title>Background</title>
                  <p>Anaphylaxis is an acute life-threatening allergic reaction and a concern at a global level; therefore, further progress in understanding the underlying mechanisms and more effective strategies for diagnosis, prevention and management are needed.</p>
                </sec>
                <sec>
                  <title>Objective</title>
                  <p>We sought to identify the global architecture of blood transcriptomic features of anaphylaxis by integrating expression data from human patients and mouse model of anaphylaxis.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>Bulk RNA-sequencings of peripheral whole blood were performed in: i) 14 emergency department (ED) patients with acute anaphylaxis, predominantly to <italic>Hymenoptera</italic> venom, ii) 11 patients with peanut allergy undergoing double-blind, placebo-controlled food challenge (DBPCFC) to peanut, iii) murine model of IgE-mediated anaphylaxis. Integrative characterisation of differential gene expression, immune cell-type-specific gene expression profiles, and functional and pathway analysis was undertaken.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>1023 genes were commonly and significantly dysregulated during anaphylaxis in ED and DBPCFC patients; of those genes, 29 were also dysregulated in the mouse model. Cell-type-specific gene expression profiles showed a rapid downregulation of blood basophil and upregulation of neutrophil signature in ED and DBPCFC patients and the mouse model, but no consistent and/or significant differences were found for other blood cells. Functional and pathway analysis demonstrated that human and mouse blood transcriptomic signatures of anaphylaxis follow trajectories of upregulation of cell movement, migration and neuroinflammatory signalling, and downregulation of lipid activating nuclear receptors signalling.</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p>Our study highlights the matched and extensive blood transcriptomic changes and suggests the involvement of discrete cellular components and upregulation of migration and neuroinflammatory pathways during anaphylaxis.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>transcriptome analysis</kwd>
                <kwd>anaphylaxis</kwd>
                <kwd>basophils</kwd>
                <kwd>neutrophils</kwd>
                <kwd>cell movement</kwd>
                <kwd>migration</kwd>
                <kwd>neuroinflammatory signaling</kwd>
                <kwd>lipid activating nuclear receptors signaling</kwd>
              </kwd-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="4"/>
                <equation-count count="0"/>
                <ref-count count="76"/>
                <page-count count="15"/>
                <word-count count="7396"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>Anaphylaxis is an acute systemic hypersensitivity reaction that is rapid in onset and usually associated with potentially life-threatening airway, breathing, and/or circulatory compromise, often with skin and mucosal changes (<xref rid="B1" ref-type="bibr">1</xref>). It is mostly triggered by food, drugs, or insect stings (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Anaphylaxis is increasingly a concern at a global level; therefore, further progress in understanding the underlying mechanisms and more effective strategies for diagnosis, prevention and management are needed (<xref rid="B1" ref-type="bibr">1</xref>–<xref rid="B4" ref-type="bibr">4</xref>).</p>
              <p>Although mast cell activation <italic>via</italic> IgE-mediated pathways is postulated to have a pivotal role in anaphylaxis, there has been steady progress in understanding that other pathways, effector cells and mediators potentially contribute to symptoms (<xref rid="B1" ref-type="bibr">1</xref>), with evidence for a potential role involving complement, basophils, neutrophils, monocytes/macrophages, platelets, and mediators, such as platelet-activating factor (PAF), cysteinyl leukotrienes (CysLTs), tryptase, and cytokines/chemokines (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>–<xref rid="B9" ref-type="bibr">9</xref>).</p>
              <p>Transcriptomic data relating to anaphylaxis in human subjects, indicate that innate immune pathways (<xref rid="B10" ref-type="bibr">10</xref>) and immune cells, such as neutrophils, naïve CD4<sup>+</sup> T cells, and macrophages are involved in the pathogenesis of human anaphylaxis (<xref rid="B11" ref-type="bibr">11</xref>). However, these data are not accomplished or integrated by transcriptomic analysis from mouse models of anaphylaxis, which have been developed to investigate the functions of antibodies, Fc receptors, and effector cells in anaphylaxis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p>
              <p>To address this evidence gap, we integrated acute transcriptomic changes (bulk RNA-sequencing) of peripheral whole blood observed during anaphylaxis (i) in patients presenting to the hospital emergency department (ED) with acute anaphylaxis triggered mostly by insect stings, (ii) in peanut-allergic patients undergoing double-blind placebo-controlled food challenge (DBPCFC), and (iii) in a study of iIL9Tg mouse model using the passive antigen-induced anaphylaxis model which mimics food-induced IgE-mediated anaphylaxis (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Integrated data revealed 1023 genes commonly and significantly dysregulated during anaphylaxis in ED and DBPCFC patients; of those genes, 29 were also dysregulated in the mouse model; and common changes in blood basophils and neutrophils, upregulation of cell movement, migration, and neuroinflammatory signalling, and downregulation of lipid activating nuclear receptors signalling.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2_1">
                <title>Study subjects</title>
                <sec id="s2_1_1">
                  <title>Emergency department study</title>
                  <p>We recruited 15 patients (8 female patients; age, 20-79 years) presenting with an acute episode of anaphylaxis to the ED of University Hospital Golnik, Slovenia (<xref rid="B6" ref-type="bibr">6</xref>). Reaction severity was graded according to the Mueller criteria (<xref rid="B14" ref-type="bibr">14</xref>). We collected blood samples at presentation to the ED and 7-14 days and/or 1 month after the anaphylactic episode (<xref rid="T1" ref-type="table"><bold>Table 1</bold></xref>).</p>
                  <table-wrap position="float" id="T1">
                    <label>Table 1</label>
                    <caption>
                      <p>Patients with acute anaphylactic reactions recruited from the hospital emergency department.</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <thead>
                        <tr>
                          <th valign="top" align="left" rowspan="1" colspan="1">No.</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Sex</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Age</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Culprit</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Mueller grade</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Time from onset of reaction to sampling*</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Emergency treatment</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">1</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">20</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">European Hornet</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">30 min, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">aH1 (2tbl, 2 mg iv) ST (64mg po, 125 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">2</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">70</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Unknown <italic>Hymenoptera</italic>
</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">2 h25 min, 14 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">aH1 (2 mg iv), ST (500 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">71</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Yellow Jacket</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">2 h 30 min, 7d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">aH1 (2 mg iv), ST (125 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">57</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">European Hornet</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">2 h 45 min, 13 d</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">aH1 (2 mg iv), ST (40 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">5</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">33</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">European Hornet</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">4 h, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">No drugs administered</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">6</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">50</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Yellow Jacket</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">1 h 20 min, 7 d, 1m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (0.3 mg im), aH1 (2tbl, 2 mg iv), ST (64 mg po, 125 mg iv), bronchodilator (fenoterol 0,5mg, ipratropium bromide 0,2mg)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">7</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">48</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Honeybee</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">1 h 20 min, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (0.3-0.5 mg im), aH1 (2 mg iv), ST (&gt;40 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">8</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">55</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Honeybee</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">3h 10 min, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (0.3 mg iv), aH1 (2tbl, 2 mg iv), ST (64 mg po, 500 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">9</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">47</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Wasp</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">2 h, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">aH1 (2 mg iv), ST (80 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">10</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">62</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">European Hornet</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">55 min, 8 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (0.5 mg im), aH1 (2 mg iv), ST (125 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">11</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">56</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Idiopathic</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">&lt;1 h, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (0.3-0.5 mg), aH1 (2mg iv), ST (125 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">12</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">56</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Wasp</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">2 h, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi, aH1, ST</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">13</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">79</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">European Hornet</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">1 h, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">aH1 (2 mg iv), ST (80 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">14</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">66</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Iv analgesic</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">20 min, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (0.3 mg im), aH1 (2 mg iv), ST (80 mg iv)</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">15</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">56</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Honeybee</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">55 min, 7 d, 1 m</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">Epi (2x 0.5 mg im), aH1 (2 mg iv), ST (125 mg iv)</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <fn>
                        <p>aH1, H<sub>1</sub>-antihistamine (clemastine); Epi, epinephrine; ST, steroid (methylprednisolone); min, minutes; d, days; m, months. European hornet (Vespa crabro); wasp (Vespula vulgaris; Polistes); honey bee (Apis mellifera).</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="s2_1_2">
                  <title>Peanut allergy study (DBPCFC study)</title>
                  <p>We recruited 11 patients with peanut allergy in whom allergy was confirmed by DBPCFCs as described elsewhere (<xref rid="B15" ref-type="bibr">15</xref>). Blood samples were collected prior to the challenge, at the onset of objective symptoms, and 2-4 hours after the challenge (<xref rid="T2" ref-type="table"><bold>Table 2</bold></xref>).</p>
                  <table-wrap position="float" id="T2">
                    <label>Table 2</label>
                    <caption>
                      <p>Patients with peanut allergy undergoing double-blind placebo-controlled food challenge to peanut.</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <thead>
                        <tr>
                          <th valign="top" align="left" rowspan="1" colspan="1">No</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Sex</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Age</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Cumulative reaction dose(mg PN protein)</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Muellergrade</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Sampling time†</th>
                          <th valign="top" align="center" rowspan="1" colspan="1">Emergency treatment</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">1</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">31</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">1333</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 2h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Epi at reaction aH1 and HC post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">2</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">15</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">143</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Pre FC, at reaction</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Epi post sampling</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">13</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">4443</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 4h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Epi, aH1, β2-agonist post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">4</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">15</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">1443</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 4h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">aH1 at reaction Epi post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">5</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">13</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">1443</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, at anaphylaxis, 4h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Epi at 1h post (time of anaphylaxis), aH1 after sampling at 1h</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">6</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">9</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">13</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 4h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">aH1, Epi after sampling at time of reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">7</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">9</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">143</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 40min post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Epi, β2-agonist post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">8</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">14</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">443</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 4h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Epi, aH1, β2-agonist, iv fluids post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">9</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">22</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">133</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 2h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">aH1, HC post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">10</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">M</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">27</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">63</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">PreFC, at reaction, 2h post</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">aH1, HC post reaction</td>
                        </tr>
                        <tr>
                          <td valign="top" align="left" rowspan="1" colspan="1">11</td>
                          <td valign="top" align="left" rowspan="1" colspan="1">F</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">13</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">143</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">3</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">Pre FC, at reaction</td>
                          <td valign="top" align="center" rowspan="1" colspan="1">aH, Epi, HC, β2-agonist after sampling</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <fn>
                        <p>aH1, H1-antihistamine; Epi, epinephrine; HC, hydrocortisone; iv, intravenous; PN, peanut. †Whole blood samples were collected into PAXgene blood tubes from a venous cannula sited prior to challenge (FC), at time of reaction, and then at the stated timepoint afterwards.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="s2_1_3">
                  <title>Mouse model of anaphylaxis (Mouse study)</title>
                  <p>For passive oral antigen-induced anaphylaxis, iIL9Tg mice were sensitised and challenged as previously described (<xref rid="B12" ref-type="bibr">12</xref>). In iIL9Tg mice, murine IL-9 is under the control of the intestine-specific promoter of the rat fatty acid–binding protein (iFABPp) gene. This promoter has been extensively used to direct the expression of genes, specifically in enterocytes of the small intestine (<xref rid="B16" ref-type="bibr">16</xref>). A consequence of constitutive expression of IL-9 in the SI is a significant increase in mast cell levels predominantly localised to intraepithelial, intercryptic, and lamina propria regions of the SI. We have previously demonstrated that administration of antigen-specific IgE (anti-TNP-IgE) and subsequently challenged with a single oral dose of antigen [TNP-ovalbumin (OVA)] induces an acute allergic reaction characterised by gastrointestinal (GI) and systemic symptoms (<xref rid="B17" ref-type="bibr">17</xref>). Briefly, mice were injected intravenously (i.v.) with 10 μg of anti-TNP-IgE (200 μL of saline) with or without IL-4C (recombinant, IL-4–neutralising, anti–IL-4 monoclonal antibody [mAb] complex, 1:5 weight) (anti–IL-4 mAb, clone BVD4-1D11.2 obtained from Fred Finkelman, CCHMC) (<xref rid="B17" ref-type="bibr">17</xref>). Twenty-four hours later, mice were held in the supine position and orally gavaged with 250 μL of TNP-Ovalbumin (Ova; 50 mg) in saline (<xref rid="B17" ref-type="bibr">17</xref>). Before the intragastric (i.g.) challenge, mice were deprived of food for 3-4 hours. Challenges were performed with i.g. feeding needles (01-290-2B; Fisher Scientific Co., Pittsburgh, PA). For passive anaphylaxis, iIL9Tg mice were injected i.v. with 10 μg of anti-IgE [EM-95; obtained from Fred Finkelman, CCHMC (<xref rid="B18" ref-type="bibr">18</xref>)] in 100 μl saline and anaphylaxis assessment performed (<xref rid="B12" ref-type="bibr">12</xref>). Hypothermia (significant loss of body temperature) was used as an indication of anaphylaxis. Rectal temperature was measured with a rectal probe and a digital thermocouple thermometer (Model BAT-12; Physitemp Instruments, Clifton, NJ, USA). Temperature was taken prior to the challenge and then every 15 min for 30 or 60 minutes to identify maximum temperature change as previously described (<xref rid="B12" ref-type="bibr">12</xref>). Control mice were defined as mice that received anti-TNP IgE and subsequently received saline <italic>via</italic> o.g. and did not experience shock (hypothermia) response 30 minutes following challenge (FC). Mice that experienced a mild to moderate reaction received anti-TNP IgE and subsequently received o.g. OVA-TNP and experienced a 1.5 - 1.9˚C temperature loss within 30 minutes of oral FC. Mice that experienced a severe reaction received anti-TNP IgE and IL-4C and o.g. OVA-TNP and experienced a ≥ 3.7°C temperature loss within 30 minutes of the FC. Peripheral whole blood was drawn from iIL9Tg mice 2 hours following the intragastric challenge.</p>
                </sec>
              </sec>
              <sec id="s2_2">
                <title>Study approval</title>
                <sec id="s2_2_1">
                  <title>Human studies</title>
                  <p>This study was conducted in accordance with the amended Declaration of Helsinki. Ethical approval was obtained from the Slovenian National Medical Ethics Committee (ED study) and the London Central Research Ethics Committee (DBPCFC study). All subjects provided written informed consent.</p>
                </sec>
                <sec id="s2_2_2">
                  <title>Animal studies</title>
                  <p>All mice were maintained and bred in a barrier facility, and animals were handled under approved Institutional Animal Care and Use Committee protocols at the University of Michigan animal facility.</p>
                </sec>
              </sec>
              <sec id="s2_3">
                <title>RNA sequencing</title>
                <sec id="s2_3_1">
                  <title>Processing of blood samples and RNA isolation</title>
                  <p>Whole blood samples were collected into Tempus™ Blood RNA tubes (Thermo Fisher Scientific, Waltham, MA, USA) or PAXgene blood tubes (Qiagen, Hilden, Germany) containing RNA stabilising reagent. Total RNA was isolated using QuickGene blood cell kit (RB-S) and Fujifilm QuickGene-810 automated system (Fujifilm Life Sciences, Tokyo, Japan) or PAXgene Blood miRNA Kit and fully automated QIAcube system (Qiagen), according to the manufacturer’s isolation protocol. The purity of isolated RNA was assessed using the NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific), and integrity was determined on Agilent 2100 Bioanalyzer using RNA 6000 Nano LabChip kit (Agilent Technologies, Santa Clara, CA, USA). All samples used for library preparation had RNA integrity values greater than 7.0. Extracted RNA samples were stored at -80°C before further processing.</p>
                </sec>
                <sec id="s2_3_2">
                  <title>Sample library preparation</title>
                  <p>We performed library preparation using the TrueSeq stranded total RNA sample preparation kit (Illumina, San Diego, CA, USA), according to the manufacturer’s protocol. After Ribo-Zero rRNA depletion, the remaining RNA was purified, fragmented, and primed for first strand cDNA synthesis with reverse transcriptase (SuperScript II) and random primers, followed by second strand cDNA synthesis performed in the presence of dUTP. Blunt-ended double-strand DNA was 3’ adenylated, and multiple indexing adapters (T-tailed) were ligated to the ends of the ds cDNA. Fragments with adapter molecules on both ends were selectively enriched with 15 cycles of PCR reaction. 44 libraries were normalised to the final concentration of 10 nM and then pooled in equimolar concentrations. Sequencing was performed on the Illumina Hiseq 2000 sequencing system in 2×100 sequencing cycles using pair-end sequencing mode.</p>
                </sec>
                <sec id="s2_3_3">
                  <title>RNAseq data analyses</title>
                  <p>After initial read quality filtering and demultiplexing using Bcl2Fastq v1.8., alignments to the human reference genome (hg19) and mouse genome (mm10) were performed bowtie and tophat alignment softwares. Transcript abundances were then estimated using read counts function in Subread package for R (<xref rid="B19" ref-type="bibr">19</xref>), followed by intersample normalisation by variance modelling at the observational level (voom) approach implemented in limma Bioconductor package (<xref rid="B20" ref-type="bibr">20</xref>). Differences in gene expression were estimated using linear modelling and significance estimation procedures in limma. Principal component analysis was performed using the built-in function in R 4.0.3. Prior to further calculations, we removed the low-expressed genes by filtering out the genes that displayed counts per million (cpm) values below 1 in over 95% of the samples tested. This enabled removal of genes characterised by the low expression across all the samples, while still retaining potential biologically relevant genes that displayed low expression in a subset of samples, but a higher expression level in others.</p>
                  <p>The significance estimations were controlled for multiple testing using the false discovery rate approach (FDR) implemented in limma, and genes with FDR values of 0.1 or less were deemed dysregulated (differentially expressed).For comparison of human and mouse transcriptional patterns, we performed the conversion of the gene identifiers using orthology data in the Ensembl database, using biomaRt package for R.</p>
                </sec>
                <sec id="s2_3_4">
                  <title>Gene set enrichment analyses</title>
                  <p>In order to gain insights into biological mechanisms during anaphylaxis and to determine whether examined gene sets show statistically significant differences between stages, we performed Gene Set Enrichment Analysis (GSEA). Normalised sample expression levels (normalised RPKM values) of genes were used in the analysis. Gene sets collections (hallmark - H, curated gene sets – C2, ontology gene sets - C5, immunologic signature gene sets - C7) were obtained from the Molecular Signature Database (MSigDB) complied by Broad Institute: <uri xlink:href="http://www.broadinstitute.org/gsea/index.jsp">http://www.broadinstitute.org/gsea/index.jsp</uri>. To assess the statistical significance of the enrichment score, we used 1000 permutations.</p>
                </sec>
                <sec id="s2_3_5">
                  <title>Immune cell-type-specific gene expression profiles</title>
                  <p>We generated the gene signatures of immune cells based on the data from published immune cell expression profiling studies. Briefly, we analysed the publicly available immune cell transcriptome data for humans (GSE3982) (<xref rid="B21" ref-type="bibr">21</xref>) and mice (GSE37448) (<xref rid="B22" ref-type="bibr">22</xref>). For each immune cell type characterised in these studies, we selected genes that performed best at differentiating a specific immune cell type from others characterised in the study (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>). For each cell type investigated in the published immune cell profiling datasets, we performed a moderated t-test comparison (limma) of gene expression of the selected cell type and compared it to expression profiles of other cell types analysed in the study. We performed this iteratively across all the cell types investigated in the published datasets. Using this approach, we identified genes that were specifically over-expressed and were therefore considered as characteristic of a specific immune cell type versus other cell types. Only genes that attained a highly significant upregulation were included in each signature (P-value &lt; 10<sup>-12</sup>). GSEA analysis was then used to detect the enrichment of gene sets belonging to each immune signature set. The list of genes included in human and mouse immune cell signatures are provided in the <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Materials</bold></xref> (<xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Tables 11</bold></xref>, <xref rid="SM1" ref-type="supplementary-material"><bold>12</bold></xref>).</p>
                </sec>
                <sec id="s2_3_6">
                  <title>Functional and pathway analysis</title>
                  <p>The functional analyses were generated through the use of QIAGEN’s Ingenuity<sup>®</sup> Pathway Analysis (IPA<sup>®</sup>, QIAGEN Redwood City, <uri xlink:href="http://www.qiagen.com/ingenuity">www.qiagen.com/ingenuity</uri>). DEGs with corresponding expression values were uploaded into the IPA software (Qiagen). The core analysis function included in the software was used to interpret the DEG data, which included diseases and functions, canonical pathways, and upstream transcriptional regulators.</p>
                </sec>
                <sec sec-type="data-availability" id="s2_3_7">
                  <title>Data availability</title>
                  <p>Raw sequencing and read-count level data were submitted to GEO repository (GSE215184).</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <sec id="s3_1">
                <title>Study participants</title>
                <sec id="s3_1_1">
                  <title>Emergency department study</title>
                  <p><xref rid="T1" ref-type="table"><bold>Table 1</bold></xref> shows detailed information on demographic and clinical characteristics, emergency treatment, and sampling data of 15 ED patients. The reaction was caused by a <italic>Hymenoptera</italic> insect sting in 13 (87%) patients. One patient had a Mueller grade I, 5 a Mueller grade III, and 9 a Mueller grade IV reaction. The median time from the onset of symptoms to peripheral blood sample collection was 1 hour 20 minutes (range 20 minutes to 4 hours). Convalescent samples were collected from all patients median 7 days (range 7 to 14 days) and 14 patients one month after the anaphylactic episode.</p>
                </sec>
                <sec id="s3_1_2">
                  <title>Peanut allergy study (Peanut-DBPCFC study)</title>
                  <p>In 11 peanut-allergic individuals, peripheral blood samples were collected prior to DBPCFC. Four patients had a Mueller grade II and 7 a Mueller grade III reaction. According to Mueller grading, the reaction severity was significantly lower in the DBPCFC group compared to the ED group (Median 3 vs 4; P = 0.002; Mann-Whitney U test). Following the objective reaction, further blood samples were obtained from all patients, and in 9, 2-4 hours after reaction. One patient (patient 5) experienced anaphylaxis 1 hour after an initial non-anaphylaxis reaction and therefore had 2 post-reaction samples collected (<xref rid="T2" ref-type="table"><bold>Table 2</bold></xref>).</p>
                </sec>
                <sec id="s3_1_3">
                  <title>Mouse model of anaphylaxis (Mouse study)</title>
                  <p>Individual transcriptomic analysis was ascertained from the blood of 8 mice with severe IL-4C amplified anaphylaxis within 30 minutes of oral challenge, 8 with mild to moderate anaphylaxis within 30 minutes of the challenge, and 7 control mice, that did not experience shock (hypothermia) response 30 minutes following challenge for baseline comparison (<xref rid="B17" ref-type="bibr">17</xref>).</p>
                </sec>
              </sec>
              <sec id="s3_2">
                <title>Anaphylaxis in humans and mice is associated with extensive and common gene dysregulation</title>
                <p>1023 genes were commonly and significantly dysregulated during anaphylaxis in ED and DBPCFC patients; of those genes, 29 were also dysregulated in the mouse model.</p>
                <p>We compared gene expression signatures during the anaphylaxis episode between different provoking agents (insect stings and peanut) and human (ED, Peanut-DBPCFC studies) or murine model of anaphylaxis. Therefore, we first compared differentially expressed genes (DEGs) between all three study groups, and found a high correlation in transcriptional response during human anaphylaxis, between ED and DBPCFC (r = 0.61, P &lt; 10<sup>-16</sup>; <xref rid="f1" ref-type="fig"><bold>Figure 1A</bold></xref>). While only limited correlation was found between human and mouse model (MOUSE and ED (r = 0.19, P &lt; 10<sup>-16</sup>); MOUSE and DBPCFC (r = 0.17, P &lt; 10<sup>-16</sup>; <xref rid="f1" ref-type="fig"><bold>Figures 1B, C</bold></xref>). Detailed analysis revealed that in the emergency department (ED) study, no differences in RNA expression when comparing the convalescent samples 7 days and 1 month after the acute allergic reaction was detected. On the other hand, significant differences in RNA expression profiles were observed when comparing samples after acute allergic reaction with either 7 days and 1 month after the episode. Therefore, in all downstream analyses, RNA expression after the acute allergic reaction was compared with merged convalescent samples after 7 days and 1 month after the episode, as 3224 differentially expressed gene (DEGs) were found during anaphylaxis in comparison to convalescent state.</p>
                <fig position="float" id="f1">
                  <label>Figure 1</label>
                  <caption>
                    <p>Comparison of gene dysregulation during the anaphylactic episode between human and mouse model of anaphylaxis: <bold>(A)</bold> between ED and DBPCFC study, <bold>(B)</bold> between MOUSE and DBPCFC study, and <bold>(C)</bold> between ED and MOUSE study. Overall 3224, 2314 and 80 genes were differentially expressed in ED, DBPCFC and mouse study group, respectively with <bold>(D)</bold> the overlap of 1023 DEGs for both human situations of anaphylaxis and 29 DEGs for all three study groups. Genes (n=29) differentially expressed in human and mouse model during anaphylaxis are highlighted. ACUTE, acute anaphylactic episode; ED, Emergency Department; DBPCFC, double-blind placebo-controlled food challenge.</p>
                  </caption>
                  <graphic xlink:href="fimmu-13-1016165-g001" position="float"/>
                </fig>
                <p>When analysing the transcriptional changes in the double-blind placebo-controlled food challenge (DBPCFC) study group, only modest changes in gene expression were detected at the cessation of the challenge in comparison to before, whereas most profound changes were detected when comparing after the challenge with before DBPCFC, where 2314 DEGs were detected. Therefore, for all subsequent analyses, RNA expression after the challenge was compared with the status before the challenge.</p>
                <p>In the Mouse study group, we compared RNA expression levels in samples with anaphylaxis (mild and severe) in comparison to mouse samples without anaphylaxis and found 80 DEGs between the two groups. Only modest changes in RNA expression levels were observed between mice with mild and severe anaphylaxis.</p>
                <p>To identify the key genes dysregulated during the anaphylactic episode we then analysed which genes are differentially expressed in all three study groups; 1023 genes were commonly and significantly dysregulated during anaphylaxis in ED and DBPCFC patients; of those genes, 29 were also dysregulated in the mouse model (q &lt; 0.1; <xref rid="f1" ref-type="fig"><bold>Figure 1D</bold></xref>). Top DEGs found only in human anaphylaxis are presented in <xref rid="T3" ref-type="table"><bold>Table 3</bold></xref>, while top overlapping DEGs regulated in anaphylaxis are presented in <xref rid="T4" ref-type="table"><bold>Table 4</bold></xref>. Details in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Tables 1</bold></xref>–<xref rid="SM1" ref-type="supplementary-material"><bold>5</bold></xref>. DEGs in peripheral whole blood might reflect alterations in transcriptional regulation or immune cell type composition, both reflecting the pathophysiological mechanism of anaphylaxis (<xref rid="B11" ref-type="bibr">11</xref>). Among the six key upregulated drivers of acute peanut allergic reactions recently identified by Watson et al. (<xref rid="B11" ref-type="bibr">11</xref>), five, specifically, <italic>KLHL2</italic>, <italic>PPP1R3D</italic>, <italic>PADI4</italic>, <italic>IL1R2</italic>, and <italic>ECHDC3</italic>, were also found to be upregulated (all q&lt;0.05) in both human ED and DBPCFC study. No dysregulation of the <italic>LTB4R</italic> gene was found in our study.</p>
                <table-wrap position="float" id="T3">
                  <label>Table 3</label>
                  <caption>
                    <p>Top differentially expressed genes (q &lt; 0.1) in human anaphylaxis (ED and DBPCFC).</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th valign="top" align="left" rowspan="1" colspan="1">GeneID</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">adj.P.Value_ED</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">logFC_ED</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">adj.P.Value_DBPCFC</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">logFC_DBPCFC</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>ARG1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.54</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.58</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>BMX</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.35</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.47</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CCR3</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.82</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.66</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CD177</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">3.04</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CDK5R1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.36</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.36</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CLEC4D</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.30</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.09</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CLEC4E</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.40</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.53</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CPA3</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-2.07</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.65</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CST7</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.30</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.96</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CYSTM1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.62</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.03</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>DUSP1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.46</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.97</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>ECHDC3</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.81</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.40</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>FOS</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.51</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.96</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>GATA2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.13</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.16</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>HDC</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-2.23</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.47</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>HRH4</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.87</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>IL18R1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.43</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.56</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>IL18RAP</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.37</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.18</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>IL1R2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.30</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.57</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>IL5RA</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.19</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.61</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>IRS2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.38</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.40</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>KLHL2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.49</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.78</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MMP9</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.93</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.13</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MYCL</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.33</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.70</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>ORM1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.27</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.46</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>OSM</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.20</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.27</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>PADI4</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.31</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.54</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>PER1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.37</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.94</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>PPP1R3D</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.39</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.61</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>PTGDR2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.21</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.88</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>SAMSN1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.74</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.27</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>SEMA7A</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.57</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.12</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>DBPCFC double-blind, placebo-controlled food challenge; ED; emergency department; FC, fold change. Differentially expressed genes are listed in alphabetical order. Downregulated genes are presented in blue and upregulated in red.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap position="float" id="T4">
                  <label>Table 4</label>
                  <caption>
                    <p>Differentially expressed genes (q &lt; 0.1) in all three study groups (human (ED and DBPCFC) and mouse study groups).</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th valign="top" align="left" rowspan="1" colspan="1">GeneID</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">adj.P.Value_ED</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">logFC_ED</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">adj.P.Value_DBPCFC</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">logFC_DBPCFC</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">adj.P.Value_MOUSE</th>
                        <th valign="top" align="center" rowspan="1" colspan="1">logFC_MOUSE</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>AK2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.31</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.40</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.99</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>ARID5A</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.98</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.07</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.51</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.17</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>ATXN10</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.24</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.45</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.77</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CCDC50</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.37</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.60</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.07</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CERS6</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.39</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.49</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.09</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CHD9</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.23</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.37</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.51</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CLEC4E</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.40</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.53</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.25</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CPNE2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.05</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.40</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.75</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">3.35</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>CRISPLD2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.52</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.99</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.91</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>FOS</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.51</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.96</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.91</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>FPR1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.46</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.70</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.05</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.52</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>FPR2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.59</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.95</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.29</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>HDC</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-2.23</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-1.47</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.79</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>HLX</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.69</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.24</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.79</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>IL1R2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.30</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.57</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">3.40</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>LMNB1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.48</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.75</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.86</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MCEMP1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.50</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.07</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.36</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.76</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MGA</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.34</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.63</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.07</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">-0.43</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MGAM</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.70</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.16</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.60</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MMP25</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.70</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.08</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.72</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.09</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.16</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MMP9</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.93</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.13</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.07</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.68</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>MXD1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.50</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.58</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.48</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>OSM</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.20</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.27</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">3.02</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>PLAUR</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.73</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.02</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.73</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.69</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>PPP1R3B</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.38</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.63</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.41</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>RAB7A</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.65</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.05</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.75</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.10</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.77</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>S100A8</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.50</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.08</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.92</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.08</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">2.06</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>SAMSN1</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">&lt;0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.74</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.04</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.27</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.60</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">
                          <italic>SBNO2</italic>
                        </td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.01</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.52</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.61</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.09</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">1.18</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>DBPCFC double-blind, placebo-controlled food challenge; ED; emergency department; FC, fold change. Differentially expressed genes are listed in alphabetical order. Downregulated genes are presented in blue and upregulated in red.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <sec id="s3_2_1">
                  <title>Rapid and common downregulation of basophil and upregulation of neutrophil gene signature in human and murine anaphylaxis</title>
                  <p>Anaphylaxis involves complex interactions, recruitment, and activities of several different immune cell types. To identify key blood immune cell types participating in anaphylaxis comparative analysis with expression signatures of basophils, B cells, dendritic cells, eosinophils, macrophages, monocytes, neutrophils, NK cells, T cells (CD4<sup>+</sup> and CD8<sup>+</sup>, Th1 and Th2), were obtained from Molecular Signature Database (MSigDB). Immune cell-type-specific gene expression profiles identified major changes in basophil and neutrophil expression signatures for all three studies: ED, DBPCFC and mouse study of anaphylaxis (<xref rid="f2" ref-type="fig"><bold>Figure 2</bold></xref>). Eosinophil signatures were different only for ED and mouse studies, but not DBPCFC study. No consistent differences were observed in the expression signatures of other immune cells (Details in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Tables 6</bold></xref>, <xref rid="SM1" ref-type="supplementary-material"><bold>7</bold></xref>).</p>
                  <fig position="float" id="f2">
                    <label>Figure 2</label>
                    <caption>
                      <p>Immune cell-specific profile changes in peripheral blood during anaphylaxis. <bold>(A)</bold> Cell-specific gene signatures of basophils, neutrophils and eosinophils are differentially expressed during anaphylaxis. <bold>(B)</bold> Changes in cell profile in peripheral blood in different time points. No consistent differences were observed in expression signatures of B cells, dendritic cells, macrophages, monocytes, NK cells, T cells (CD4+ and CD8+, Th1 and Th2) (Details in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Tables 6, 7</bold></xref>). ACUTE, acute anaphylactic episode; ED, Emergency Department; DBPCFC, double-blind placebo-controlled food challenge. *P &lt;0.05, **P &lt;0.01, ***P &lt;0.001, and ***P &lt;0.0001 by the Mann-Whitney test.</p>
                    </caption>
                    <graphic xlink:href="fimmu-13-1016165-g002" position="float"/>
                  </fig>
                  <p>During anaphylaxis, we observed a significant decrease in basophil gene signature and an increase in neutrophil specific gene signature, and those changes were evident in all three study groups (<xref rid="f2" ref-type="fig"><bold>Figures 2A, B</bold></xref>). In the DBPCFC study, trends in basophil and neutrophil changes already become evident at the onset of objective anaphylactic symptoms and then achieved significance at post sampling (<xref rid="f2" ref-type="fig"><bold>Figure 2B</bold></xref>). Eosinophil specific gene signature was increased only in the ED study, but not under the controlled setting of the DBPCFC study, while in the mouse study group it was increased in mice with severe anaphylaxis (<xref rid="f2" ref-type="fig"><bold>Figure 2</bold></xref>). The changes in gene expression signatures of basophils and neutrophils might represent either a change in the number of these cells (reflecting movement and/or migration of these cells) and/or changes in distinct basophil and neutrophil subsets with specific/different functional consequences.</p>
                </sec>
                <sec id="s3_2_2">
                  <title>Gene signatures indicate regulation of cell movement and migration as well as chronic inflammation in integrated human and murine anaphylaxis</title>
                  <p>To illustrate interactions, biological context and bio-function among the top DEGs during anaphylaxis, a network and pathway analysis was performed and the top terms enriched in all three study groups and each category are presented in <xref rid="f3" ref-type="fig"><bold>Figure 3</bold></xref>.</p>
                  <fig position="float" id="f3">
                    <label>Figure 3</label>
                    <caption>
                      <p>Comparison of altered Diseases and functions, Canonical pathways and Upstream regulators during anaphylaxis between different study groups: <bold>(A)</bold> ED and DBPCFC, <bold>(B)</bold> ED and MOUSE, <bold>(C)</bold> DBPCFC and MOUSE. The plot is based on the z score calculations obtained for a given set of genes using the IPA analysis. The positive values indicate an overall upregulation (red colour) of the genes in a set and negative values indicate a downregulation (blue colour). The colour of the points corresponds to a mean of z scores obtained for the pair of exposures in each panel, and the size of the points corresponds to an absolute average of z scores. The larger and more intensely coloured points, therefore, indicate a more pronounced and analogous dysregulation of a gene set in a given pair of exposures. Details in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Table 8</bold></xref> (Diseases and functions), <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Table 9</bold></xref> (Canonical pathways) and <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Table 10</bold></xref> (Upstream regulators).</p>
                    </caption>
                    <graphic xlink:href="fimmu-13-1016165-g003" position="float"/>
                  </fig>
                  <p>Enrichment of DEGs shows that increased cell movement and migration involving different immune cells represent the most important bio-function in peripheral blood during anaphylaxis. Therefore, as also demonstrated with immune cell-type-specific gene expression profiles, migration and activation of different immune cells – most notably basophils and neutrophils – represent key mechanisms in human and murine anaphylaxis.</p>
                  <p>Diseases and functions analysis showed that the upregulated DEGs were significantly enriched in biological functions related to cell movement (z score = 2.58, P = 1.19×10<sup>-15</sup>; z score = 2.04, P = 9.58×10<sup>-7</sup>; z score = 2.68, P = 2.64×10<sup>-10</sup> for ED, DBPCFC and MOUSE study groups, respectively), the quantity of cells and migration of cells (z score = 2.06, P = 9.54×10<sup>-17</sup>; z score = 1.27, P = 1.04×10<sup>-5</sup> z score = 2.49, P = 6.52×10<sup>-10</sup> for ED, DBPCFC and MOUSE study groups, respectively), while the downregulated DEGs were enriched in functions related to chronic inflammatory disorders (z score = -2.05, P = 3.84×10<sup>-14</sup>; z score = -0.42, P = 3.57×10<sup>-5</sup>; z score = -0.90, P = 4.31×10<sup>-12</sup> for ED, DBPCFC and MOUSE study groups, respectively). Details in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Table 8</bold></xref>.</p>
                </sec>
                <sec id="s3_2_3">
                  <title>IPA identifies regulation of acute response, neuroinflammatory and lipid activating nuclear receptors signalling in integrated human and murine anaphylaxis</title>
                  <p>The most significantly enriched canonical pathways of the upregulated DEGs were acute phase response (<italic>z</italic> scores were 1.98, 2.18, and 1.13, for ED, DBPCFC and MOUSE study groups, respectively), IL-8 signalling (<italic>z</italic> scores were 2.98, 1.21, and 1.34, for ED, DBPCFC and MOUSE study groups, respectively), signalling in T lymphocytes, and neuroinflammatory signalling pathway. For the downregulated DEGs, the most significantly enriched pathways were for lipid-activated nuclear receptors of transcription factors (PPAR (<italic>z</italic> scores were -1.34, -0.78, and -2.24, for ED, DBPCFC and MOUSE study groups, respectively) and LXR/RXR [<italic>z</italic> scores were -0.73, -1.39, and -2.12, for ED, DBPCFC and MOUSE study groups, respectively)] signalling. Further details are in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Table 9</bold></xref>.</p>
                  <p>Upstream regulator analysis revealed that LPS-like response (<italic>z</italic> scores were 3.30, 3.41, and 4.87, for ED, DBPCFC and MOUSE study groups, respectively), TNF (<italic>z</italic> scores were 2.58, 2.16, and 4.01, for ED, DBPCFC and MOUSE study groups, respectively), IL-6, NF-κB (<italic>z</italic> scores were 1.15, 2.40, and 2.00, for ED, DBPCFC and MOUSE study groups, respectively), EGF, and platelet-derived growth factor (PDGF-BB; <italic>z</italic> scores were 3.60, 1.98, and 2.58, for ED, DBPCFC and MOUSE study groups, respectively)) were the most significantly upregulated pathways during anaphylaxis in all three study groups. While alpha-catenin (<italic>z</italic> scores were -2.11, -2.61, and -2.60, for ED, DBPCFC and MOUSE study groups, respectively) and inhibitors of mitogen-activated protein kinases (OU126, PD98059, H89, SB2003580) being among the most downregulated upstream regulators during anaphylaxis. Further details are in <xref rid="SM1" ref-type="supplementary-material"><bold>Supplementary Table 10</bold></xref>.</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>Herein, we have integrated analysis of ED insect sting and controlled DBPCFC peanut human studies with mouse study of anaphylaxis to identify the global architecture of blood transcriptome features of anaphylaxis. The iIL9Tg mouse model permits the induction of an IgE-mediated food allergic reaction following a single oral dose of antigen, as in human anaphylaxis (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Our study highlights the extensive blood transcriptomic changes, which included dysregulation of 1023 genes in human anaphylaxis and 29 genes that were dysregulated in both human and mouse anaphylaxis, the involvement of blood basophils and neutrophils, and upregulation of cell movement, migration, neuroinflammatory signalling, and downregulation of lipid activating nuclear receptors signalling during anaphylaxis. Notably, the extent and correlations of the transcriptomic changes in human anaphylaxis (1023 genes; correlation coefficient r = 0.61) versus that induced in both human and mouse anaphylaxis (29 genes; correlation coefficients r = 0.17 and 0.19) differ significantly.Among the six key drivers of acute peanut allergic reactions previously identified by Watson et al. (<xref rid="B11" ref-type="bibr">11</xref>), five of six, specifically <italic>PADI4</italic>, <italic>IL1R2</italic>, <italic>PPP1R3D</italic>, <italic>KLHL2</italic>, and <italic>ECHDC3</italic>, but not <italic>LTB4R</italic>, were found to be dysregulated in ED and DBPCFC studies, supporting the importance of those genes in human anaphylaxis and the relevance of previous results (<xref rid="B11" ref-type="bibr">11</xref>). However, of those 6 genes, only <italic>IL1R2</italic> was dysregulated in the mouse study. Importantly, <italic>IL1R2</italic> was recently identified as one of the genes associated with reaction severity in peanut-allergic children (<xref rid="B25" ref-type="bibr">25</xref>). IL-1R2 is expressed by neutrophils, B cells, monocytes, and macrophages, and it is a decoy receptor that neutralises IL-1β, limiting the activation of the pro-inflammatory IL-1 pathway, and influencing the production of different interleukins and NF-κB signalling (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B26" ref-type="bibr">26</xref>). OSM, oncostatin M, and IL-6 family cytokines are potent neutrophil recruiters (<xref rid="B27" ref-type="bibr">27</xref>). OSM stimulates endothelial cell proliferation and migration (<xref rid="B28" ref-type="bibr">28</xref>) and is implicated in endothelial signalling (<xref rid="B29" ref-type="bibr">29</xref>) and activation (<xref rid="B30" ref-type="bibr">30</xref>). Besides, OSM upregulates matrix metalloproteinase-9 (MMP9) through the MAPK/ERK pathway. <italic>MMP9</italic> is an important pro-inflammatory protein, which is involved in activation of mast cells (<xref rid="B31" ref-type="bibr">31</xref>) and tissue remodelling (<xref rid="B10" ref-type="bibr">10</xref>) and was also identified in our study. The most important source of MMP9 is reported to be activated neutrophils (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B31" ref-type="bibr">31</xref>). <italic>CCDC50</italic>, and <italic>SBNO2</italic> are involved in NF-κB signalling, <italic>ARID5A, FOS, MGA, MXD1</italic>, and <italic>S100A8</italic> in cellular proliferation, differentiation and apoptosis, and <italic>CD177</italic>, <italic>CPNE2, CST7, FPR1, FPR2, HLX, HRH4, IL5RA, MCEMP1, ORM1, PTGDR2</italic>, and <italic>SBNO2</italic> in immune system regulation and signalling (<xref rid="B32" ref-type="bibr">32</xref>).</p>
              <p>Multiple lines of evidence suggest that, besides mast cells viewed as key players, discrete cells may contribute to the pathology of anaphylaxis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B33" ref-type="bibr">33</xref>). By employing immune cell-type-specific gene expression profiles analysis (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>), we showed a rapid change in basophils and neutrophil signatures during anaphylaxis. However, the importance of basophils and neutrophils in the pathophysiology of anaphylaxis is currently unsettled (<xref rid="B1" ref-type="bibr">1</xref>). Nevertheless, a rapid and significant decrease in basophil gene signature during anaphylaxis supports speculations that basophil migrate from the circulation rapidly upon allergen challenge (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B34" ref-type="bibr">34</xref>), possibly to sites of inflammation (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>) where they might have an effector role (<xref rid="B34" ref-type="bibr">34</xref>). Alternatively this migration might have a protection role by limiting basophil activation in circulation (<xref rid="B34" ref-type="bibr">34</xref>). Basophil migration might be mediated by the chemokine CCL2, levels of which are increased during anaphylaxis (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>) and which can induce selective migration of human basophils (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B37" ref-type="bibr">37</xref>).</p>
              <p>Recent data suggests that neutrophils are not only important in murine anaphylaxis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B38" ref-type="bibr">38</xref>) but might be also important in human anaphylaxis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B8" ref-type="bibr">8</xref>). This is supported by our findings of a rapid increase in neutrophil gene signature in both human ED insect sting and controlled DBPCFC peanut studies and consistent with a previous study in peanut-allergic children in which allergen challenge (but not placebo) upregulates neutrophil gene signatures (<xref rid="B11" ref-type="bibr">11</xref>). Human and murine neutrophils express several activating FcµRs and human neutrophils also FcϵRI, can release histamine (although in much smaller amounts than mast cells), PAF (which can cause bronchoconstriction, increased vascular permeability, chemotaxis, and degranulation of eosinophils and neutrophils) and CysLTs after stimulation with immune complexes (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B8" ref-type="bibr">8</xref>). In murine models of anaphylaxis, neutrophil depletion can ameliorate anaphylaxis. A potential contribution of neutrophils during anaphylaxis in humans is supported by increased serum levels of PAF (<xref rid="B9" ref-type="bibr">9</xref>) and myeloperoxidase (MPO), the major enzyme stored in neutrophils (<xref rid="B39" ref-type="bibr">39</xref>). Recently, increased neutrophil activation markers were also demonstrated during drug, food, and insect-induced anaphylaxis (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B40" ref-type="bibr">40</xref>).</p>
              <p>Aside from basophils and neutrophils, we also observed increased eosinophil gene signatures, but only in patients of the ED study and mice with severe anaphylaxis. Eosinophils express FcϵRI as well as several other receptors (including IL-5 receptor and CCR5) on their surface; their engagement induces eosinophil activation and the release of several mediators including cationic proteins (eosinophil peroxidase, major basic protein, eosinophil cationic protein, eosinophil-derived neurotoxin), lipid mediators (LTC4, PAF), and a variety of cytokines (IL-1, IL-3, IL-4, IL-5, IL-13, GM-CSF, TGF-α/β, TNF-α, chemokines (CCL3, CCL5, CCL11), and neuromodulators (Substance P, vasoactive intestinal peptide) (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B41" ref-type="bibr">41</xref>–<xref rid="B43" ref-type="bibr">43</xref>) – which could sustain or augment the immune response. However, no previous data did show that eosinophils may play a role in anaphylaxis.</p>
              <p>Integrated data-driven functional and pathway analysis using IPA disease and function, canonic pathways, and upstream regulator analysis identified cell movement, migration, and neuroinflammatory and lipid activating nuclear receptors signalling as the major blood-related pathways of anaphylaxis. Upregulation of cell movement and migration is consistent with the rapid change in basophils and neutrophil signatures during anaphylaxis and emphasises the potential importance of cellular interactions in anaphylaxis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Neurogenic inflammation may be a key driver of some allergic symptoms (<xref rid="B44" ref-type="bibr">44</xref>), including rhinitis, conjunctivitis, coughing, bronchoconstriction, airway mucus secretion, dysphagia, altered gastrointestinal motility, and urticaria/angioedema (<xref rid="B44" ref-type="bibr">44</xref>). Allergen-induced activation of mast cells could lead to alterations in the function of afferent neurons like intrapulmonary airway C-fiber (<xref rid="B45" ref-type="bibr">45</xref>), neurons within the CNS (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>), and somatosensory itch fiber in the skin (<xref rid="B48" ref-type="bibr">48</xref>), sensory nerve excitability (<xref rid="B49" ref-type="bibr">49</xref>) and neuroplasticity (<xref rid="B50" ref-type="bibr">50</xref>), increases in synaptic efficacy in autonomic ganglia (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>) and stimulation of enteric neurons (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>) – an effect which might be more prominent in atopic individuals compared to non-atopic controls (<xref rid="B44" ref-type="bibr">44</xref>). Of note, a recent neuronal receptor-based controlling mechanism of anaphylaxis involving the glutamatergic receptor mGluR7was described (<xref rid="B55" ref-type="bibr">55</xref>). These data would therefore be consistent with our hypothesis that upregulation of neuroinflammatory signalling pathways might impact neuromodulation in anaphylaxis.</p>
              <p>Lipid-activating nuclear receptors signalling, specifically lipid-activated nuclear receptors of transcription factors PPAR and LXR/RXR, was found to be highly downregulated. Ligand-activated transcription factors play important roles in cellular processes such as differentiation, proliferation, survival, apoptosis, and motility in a variety of biological contexts, including inflammation and immune responses (<xref rid="B56" ref-type="bibr">56</xref>). LXR and PPAR can antagonise inflammatory pathways through transrepression (<xref rid="B57" ref-type="bibr">57</xref>). PPARs can modulate the intensity, duration, and outcomes of inflammatory responses through anti-inflammatory effects (<xref rid="B58" ref-type="bibr">58</xref>). PPAR activation also reduces the production of multiple pro-inflammatory mediators, including TNF-α, IL-1α, IL-6, and IL-8. PPAR activation in endothelial cells inhibits endothelial inflammation, improves endothelial function, and inhibits cell proliferation and migration (<xref rid="B59" ref-type="bibr">59</xref>). Downregulation/inhibition of these effects thus results in vascular dysregulation. Lipid-activated nuclear receptors also shape macrophage and dendritic cell function (<xref rid="B60" ref-type="bibr">60</xref>), and studies in mice have shown that depletion of monocytes/macrophages can reduce anaphylaxis (<xref rid="B1" ref-type="bibr">1</xref>).</p>
              <p>There was also upregulation of NFκB signalling and lipopolysaccharide (LPS) pathway, upregulation of inflammatory cytokines IL-6, IL-8, TNF-α, and IL-1β, and angiogenic platelet-derived growth factor (PDGF). These cytokines induce the inactivation of cadherin, which mediates cell adhesion and lead to vascular leakage by increased capillary permeability and target several immune cells with the FcγR receptor (involved in acute inflammatory responses) (<xref rid="B61" ref-type="bibr">61</xref>). LPS modulates immune responses by interacting with toll-like receptor 4 (TLR4, and can induce both Th1 and Th2 responses (<xref rid="B62" ref-type="bibr">62</xref>). PDGF is synthesised and released by platelets upon activation and is increased in children with anaphylaxis; rapid IgE desensitisation, in turn, downregulates PDGF (<xref rid="B63" ref-type="bibr">63</xref>).</p>
              <p>There are some important limitations to our study. The first and most significant limitation is that we did not perform follow-up functional <italic>in-vitro</italic> experiments and analyses. However, it is important to note that recent studies corroborate possible contributing mechanisms of many of our major discovery genes (<italic>ARG1</italic>, <italic>CPA3</italic>, <italic>FOS</italic>, <italic>GATA2</italic>, <italic>HDC</italic>, <italic>IL18R1</italic>, <italic>IL18RAP</italic>, <italic>MMP9</italic>, <italic>OSM</italic>, and <italic>PER1</italic>) and related them to mast cells or basophils, or other contributing factors. Thus, Do et al. (<xref rid="B25" ref-type="bibr">25</xref>) recently identified <italic>ARG1</italic> as a major hub in the network of the genetic and epigenetic architecture of reaction severity in peanut allergy. Dwyer et al. (<xref rid="B64" ref-type="bibr">64</xref>) demonstrated that shared mast cell and basophil gene signature networks include ten-fold higher expression of <italic>CPA3</italic> and <italic>GATA2</italic> than other immune cells. Further, the transcription factor GATA2 regulates <italic>HDC</italic> gene expression in mast cells and is required for IgE/mast cell-mediated anaphylaxis (<xref rid="B65" ref-type="bibr">65</xref>), and conditional deletions of <italic>HDC</italic> confirm the role of histamine in IgE-mediated anaphylaxis (<xref rid="B66" ref-type="bibr">66</xref>). Inhibition of <italic>FOS</italic> expression attenuates IgE−mediated mast cell activation and allergic inflammation (<xref rid="B67" ref-type="bibr">67</xref>). Genetic variations at the IL-18 locus (<italic>IL18R1</italic> and <italic>IL18RAP</italic>) were associated with exercise-induced anaphylaxis (<xref rid="B68" ref-type="bibr">68</xref>), while <italic>MMP9</italic> and <italic>OSM</italic> provide evidence for the involvement of innate immune pathways (<xref rid="B40" ref-type="bibr">40</xref>). OSM is also involved in hyper-IgE syndrome (<xref rid="B69" ref-type="bibr">69</xref>). Finally, increased expression of <italic>PER1</italic> inhibits mTORC1 signalling, thus reducing Th1 differentiation and shifting the T-helper subset balance towards Th2 (<xref rid="B70" ref-type="bibr">70</xref>). Another important limitation is that due to the relatively small number of included subjects, additional subanalysis by stratifying patients according to reaction severity and trigger could not be performed. Further, bulk RNA-sequencing data was based on a mixed cell population from peripheral blood. Therefore, variations in the immune cell composition of the samples may impact the transcriptional profile. However, to our knowledge, this is the first report of integrated transcriptomic analysis of human anaphylaxis (ED patients with acute reaction, predominantly to <italic>Hymenoptera</italic> venom and patients with peanut allergy undergoing DBPCFC to peanut) and iIL9T mouse model, which mimics food-induced IgE-mediated anaphylaxis. Additionally, it was recently proposed that <italic>Hymenoptera</italic> venom and medications such as quinolone antibiotics can cause non–IgE-mediated anaphylaxis through the activation of Mas-related G protein-coupled receptor X2 (MRGPRX2) on mast cells (<xref rid="B71" ref-type="bibr">71</xref>–<xref rid="B73" ref-type="bibr">73</xref>). For <italic>Hymenoptera</italic> venom, this novel and intriguing concept is based on a venom constituent mastoparan, which can directly, through MRGPRX2, activate mast cells (<xref rid="B74" ref-type="bibr">74</xref>–<xref rid="B76" ref-type="bibr">76</xref>). Thus, direct activation of mast cells by mastoparan <italic>via</italic> this receptor (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B74" ref-type="bibr">74</xref>) may also affect transcriptomic changes observed in our ED patients. However, a broader assessment will be required to replicate these findings (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B74" ref-type="bibr">74</xref>) and confirm this hypothesis.</p>
              <p>In summary, integrative blood transcriptomic analysis in human and murine model of anaphylaxis demonstrated extensive gene dysregulation, mainly involved in NF-κB, MAPK/ERK and endothelial signalling, inflammation, cellular proliferation, differentiation, apoptosis, and immune system regulation and signalling. Importantly, we confirmed, in both human and mouse studies, the rapid changes in blood basophils and neutrophils signatures during anaphylaxis. For the first time, we have identified the upregulation of cell movement, migration, and neuroinflammatory signalling during anaphylaxis. These findings highlight the involvement of distinct effector cells, and complex signalling changes, which reflect cellular movement and interactions, as well as possible implications of the nervous system. Further studies of those pathways might be important for more effective strategies for preventing this disorder and might, in future, also provide novel options for treating anaphylaxis.</p>
            </sec>
            <sec sec-type="data-availability" id="s5">
              <title>Data availability statement</title>
              <p>The data presented in this study are deposited in the GEO repository, accession number GSE215184.</p>
            </sec>
            <sec sec-type="ethics-statement" id="s6">
              <title>Ethics statement</title>
              <p>This study was conducted in accordance with the amended Declaration of Helsinki. Ethical approval was obtained from the Slovenian National Medical Ethics Committee (ED study) and the London Central Research Ethics Committee (DBPCFC study). All subjects provided written informed consent. Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin. All mice were maintained and bred in a barrier facility, and animals were handled under approved Institutional Animal Care and Use Committee protocols at the University of Michigan animal facility.</p>
            </sec>
            <sec sec-type="author-contributions" id="s7">
              <title>Author contributions</title>
              <p>MR, AM, PK conceived the idea and designed the experiments; MR, AM, PT, KH, MK, AY, SH, AC, BP, PK acquired clinical data, performed experiments, data analysis and interpretation. MR, PK wrote the manuscript. All authors read, revised and approved the final version of the manuscript.</p>
            </sec>
          </body>
          <back>
            <sec sec-type="funding-information" id="s8">
              <title>Funding</title>
              <p>Slovenian Research Agency (P3-0360), NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London, and National Institutes of Health (AI138177 and AI112626).</p>
            </sec>
            <ack>
              <title>Acknowledgments</title>
              <p>We thank all the patients, as well as the clinical and laboratory staff for their assistance.</p>
            </ack>
            <fn-group>
              <title>Abbreviations</title>
              <fn fn-type="abbr">
                <p>CysLTs, Cysteinyl Leukotrienes; DEG, Differentially Expressed Gene; DBPCFC, Double-Blind Placebo-Controlled Food Challenge; ED, Emergency Department; EGF, Epidermal Growth Factor; ERK, Extracellular Signal-Regulated Kinase; GEO; Gene Expression Omnibus; GSEA; Gene Set Enrichment Analysis; IL, Interleukin; iIL9Tg; Intestinal IL-9 transgenic; i.g., Intragastric; IPA; Ingenuity Pathway Analysis; i.v.; Intravenously; LPS; Lipopolysaccharide; LXR/RXR, Liver X Receptor-Retinoid X Receptor; mAb; Monoclonal Antibody; MAPK, Mitogen−Activated Protein Kinase; MPO, Myeloperoxidase; MSigDB; Molecular Signature Database; NF-κB, Nuclear Factor-κB; PAF, Platelet-Activating Factor; PDGF, Platelet-Derived Growth Factor; PPAR, Peroxisome Proliferator-Activated Receptor; RPKM, Reads Per Kilobase Million; TLR4, Toll-Like Receptor.</p>
              </fn>
            </fn-group>
            <sec sec-type="COI-statement" id="s10">
              <title>Conflict of interest</title>
              <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
            </sec>
            <sec sec-type="disclaimer" id="s11">
              <title>Publisher’s note</title>
              <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
            </sec>
            <sec sec-type="supplementary-material" id="s12">
              <title>Supplementary material</title>
              <p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016165/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016165/full#supplementary-material</ext-link>
</p>
              <supplementary-material id="SM1" position="float" content-type="local-data">
                <media xlink:href="Table_1.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM2" position="float" content-type="local-data">
                <media xlink:href="Table_2.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM3" position="float" content-type="local-data">
                <media xlink:href="Table_3.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM4" position="float" content-type="local-data">
                <media xlink:href="Table_4.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM5" position="float" content-type="local-data">
                <media xlink:href="Table_5.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM6" position="float" content-type="local-data">
                <media xlink:href="Table_6.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM7" position="float" content-type="local-data">
                <media xlink:href="Table_7.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM8" position="float" content-type="local-data">
                <media xlink:href="Table_8.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM9" position="float" content-type="local-data">
                <media xlink:href="Table_9.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM10" position="float" content-type="local-data">
                <media xlink:href="Table_10.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM11" position="float" content-type="local-data">
                <media xlink:href="Table_11.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="SM12" position="float" content-type="local-data">
                <media xlink:href="Table_12.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="B1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reber</surname><given-names>LL</given-names></name><name><surname>Hernandez</surname><given-names>JD</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group>. <article-title>The pathophysiology of anaphylaxis</article-title>. <source>J Allergy Clin Immunol</source> (<year>2017</year>) <volume>140</volume>:<page-range>335–48</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2017.06.003</pub-id>
</mixed-citation>
              </ref>
              <ref id="B2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>JE</given-names></name><name><surname>Lin</surname><given-names>RY</given-names></name></person-group>. <article-title>The epidemiology of anaphylaxis</article-title>. <source>Clin Rev Allergy Immunol</source> (<year>2018</year>) <volume>54</volume>:<page-range>366–74</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s12016-015-8503-x</pub-id>
</mixed-citation>
              </ref>
              <ref id="B3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>PJ</given-names></name><name><surname>Gowland</surname><given-names>MH</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Ierodiakonou</surname><given-names>D</given-names></name><name><surname>Harper</surname><given-names>N</given-names></name><name><surname>Garcez</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Increase in anaphylaxis-related hospitalisations but no increase in fatalities: An analysis of united kingdom national anaphylaxis data, 1992-2012</article-title>. <source>J Allergy Clin Immunol</source> (<year>2015</year>) <volume>135</volume>:<page-range>956–63</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2014.10.021</pub-id>
</mixed-citation>
              </ref>
              <ref id="B4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LoVerde</surname><given-names>D</given-names></name><name><surname>Iweala</surname><given-names>OI</given-names></name><name><surname>Eginli</surname><given-names>A</given-names></name><name><surname>Krishnaswamy</surname><given-names>G</given-names></name></person-group>. <article-title>Anaphylaxis</article-title>. <source>Chest</source> (<year>2018</year>) <volume>153</volume>:<page-range>339–48</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.chest.2017.07.033</pub-id>
</mixed-citation>
              </ref>
              <ref id="B5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>JJ</given-names></name><name><surname>Chovanec</surname><given-names>J</given-names></name><name><surname>O’Connell</surname><given-names>MP</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Šelb</surname><given-names>J</given-names></name><name><surname>Zanotti</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1</article-title>. <source>J Allergy Clin Immunol</source> (<year>2021</year>) <volume>147</volume>:<page-range>622–32</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2020.06.035</pub-id>
</mixed-citation>
              </ref>
              <ref id="B6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korosec</surname><given-names>P</given-names></name><name><surname>Turner</surname><given-names>PJ</given-names></name><name><surname>Silar</surname><given-names>M</given-names></name><name><surname>Kopac</surname><given-names>P</given-names></name><name><surname>Kosnik</surname><given-names>M</given-names></name><name><surname>Gibbs</surname><given-names>BF</given-names></name><etal/></person-group>. <article-title>Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis</article-title>. <source>J Allergy Clin Immunol</source> (<year>2017</year>) <volume>140</volume>:<page-range>750–8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2016.12.989</pub-id>
</mixed-citation>
              </ref>
              <ref id="B7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vantur</surname><given-names>R</given-names></name><name><surname>Rihar</surname><given-names>M</given-names></name><name><surname>Koren</surname><given-names>A</given-names></name><name><surname>Rijavec</surname><given-names>M</given-names></name><name><surname>Kopac</surname><given-names>P</given-names></name><name><surname>Bidovec-Stojkovic</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Chemokines during anaphylaxis: The importance of CCL2 and CCL2-dependent chemotactic activity for basophils</article-title>. <source>Clin Transl Allergy</source> (<year>2020</year>) <volume>10</volume>:<fpage>1</fpage>–<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s13601-020-00367-2</pub-id>
<pub-id pub-id-type="pmid">31908763</pub-id></mixed-citation>
              </ref>
              <ref id="B8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>F</given-names></name><name><surname>Mancardi</surname><given-names>DA</given-names></name><name><surname>Albanesi</surname><given-names>M</given-names></name><name><surname>Bruhns</surname><given-names>P</given-names></name></person-group>. <article-title>Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions</article-title>. <source>J Leukoc Biol</source> (<year>2013</year>) <volume>94</volume>:<page-range>643–56</page-range>. doi: <pub-id pub-id-type="doi">10.1189/jlb.1212623</pub-id>
</mixed-citation>
              </ref>
              <ref id="B9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadas</surname><given-names>P</given-names></name><name><surname>Gold</surname><given-names>M</given-names></name><name><surname>Perelman</surname><given-names>B</given-names></name><name><surname>Liss</surname><given-names>GM</given-names></name><name><surname>Lack</surname><given-names>G</given-names></name><name><surname>Blyth</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis</article-title>. <source>N Engl J Med</source> (<year>2008</year>) <volume>358</volume>:<fpage>28</fpage>–<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa070030</pub-id>
<pub-id pub-id-type="pmid">18172172</pub-id></mixed-citation>
              </ref>
              <ref id="B10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>SF</given-names></name><name><surname>Bosco</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Cotterell</surname><given-names>CL</given-names></name><name><surname>Van Eeden</surname><given-names>PE</given-names></name><name><surname>Arendts</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Genomic responses during acute human anaphylaxis are characterised by upregulation of innate inflammatory gene networks</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<fpage>1</fpage>–<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0101409</pub-id>
</mixed-citation>
              </ref>
              <ref id="B11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>CT</given-names></name><name><surname>Cohain</surname><given-names>AT</given-names></name><name><surname>Griffin</surname><given-names>RS</given-names></name><name><surname>Chun</surname><given-names>Y</given-names></name><name><surname>Grishin</surname><given-names>A</given-names></name><name><surname>Hacyznska</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Integrative transcriptomic analysis reveals key drivers of acute peanut allergic reactions</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>:<fpage>1943</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-02188-7</pub-id>
<pub-id pub-id-type="pmid">29203772</pub-id></mixed-citation>
              </ref>
              <ref id="B12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamani</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Waggoner</surname><given-names>L</given-names></name><name><surname>Noah</surname><given-names>T</given-names></name><name><surname>Koleske</surname><given-names>AJ</given-names></name><name><surname>Finkelman</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The vascular endothelial specific IL-4 receptor alpha-ABL1 kinase signaling axis regulates the severity of IgE-mediated anaphylactic reactions</article-title>. <source>J Allergy Clin Immunol</source> (<year>2018</year>) <volume>142</volume>:<page-range>1159–72</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2017.08.046</pub-id>
</mixed-citation>
              </ref>
              <ref id="B13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Tomar</surname><given-names>S</given-names></name><name><surname>Schuler</surname><given-names>CF</given-names></name><name><surname>Hogan</surname><given-names>SP</given-names></name></person-group>. <article-title>IL-4 receptor alpha signaling alters oral food challenge and immunotherapy outcomes in mice</article-title>. <source>J Allergy Clin Immunol</source> (<year>2022</year>) <volume>S0091-6749</volume>(<issue>22</issue>). doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2022.07.011</pub-id>
</mixed-citation>
              </ref>
              <ref id="B14">
                <label>14</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>UR</given-names></name></person-group>. <article-title>Clinical presentation and pathogenesis</article-title>. In: <person-group person-group-type="editor"><name><surname>Mueller</surname><given-names>UR</given-names></name></person-group>, editor. <source>Insect sting allergy</source>. <publisher-loc>Stuttgart</publisher-loc>: <publisher-name>Gustav Fischer</publisher-name> (<year>1990</year>). p. <fpage>33</fpage>–<lpage>65</lpage>.</mixed-citation>
              </ref>
              <ref id="B15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Cano</surname><given-names>R</given-names></name><name><surname>Pascal</surname><given-names>M</given-names></name><name><surname>Bartra</surname><given-names>J</given-names></name><name><surname>Picado</surname><given-names>C</given-names></name><name><surname>Valero</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><etal/></person-group>. <article-title>Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis</article-title>. <source>J Allergy Clin Immunol</source> (<year>2016</year>) <volume>137</volume>:<page-range>137–46</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2015.05.042</pub-id>
</mixed-citation>
              </ref>
              <ref id="B16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweetser</surname><given-names>DA</given-names></name><name><surname>Birkenmeier</surname><given-names>EH</given-names></name><name><surname>Hoppe</surname><given-names>PC</given-names></name><name><surname>McKeel</surname><given-names>DW</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes</article-title>. <source>Genes Dev</source> (<year>1988</year>) <volume>2</volume>:<page-range>1318–32</page-range>. doi: <pub-id pub-id-type="doi">10.1101/gad.2.10.1318</pub-id>
</mixed-citation>
              </ref>
              <ref id="B17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahrens</surname><given-names>R</given-names></name><name><surname>Osterfeld</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Arumugam</surname><given-names>M</given-names></name><name><surname>Groschwitz</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice</article-title>. <source>Am J Pathol</source> (<year>2012</year>) <volume>180</volume>:<page-range>1535–46</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.ajpath.2011.12.036</pub-id>
</mixed-citation>
              </ref>
              <ref id="B18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baniyash</surname><given-names>M</given-names></name><name><surname>Eshhar</surname><given-names>Z</given-names></name></person-group>. <article-title>Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE</article-title>. <source>Eur J Immunol</source> (<year>1984</year>) <volume>14</volume>:<fpage>799</fpage>–<lpage>807</lpage>. doi: <pub-id pub-id-type="doi">10.1002/eji.1830140907</pub-id>
<pub-id pub-id-type="pmid">6207029</pub-id></mixed-citation>
              </ref>
              <ref id="B19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group>. <article-title>The r package rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads</article-title>. <source>Nucleic Acids Res</source> (<year>2019</year>) <volume>47</volume>:<elocation-id>e47</elocation-id>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkz114</pub-id>
<pub-id pub-id-type="pmid">30783653</pub-id></mixed-citation>
              </ref>
              <ref id="B20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group>. <article-title>Voom: Precision weights unlock linear model analysis tools for RNA-seq read counts (2014)</article-title>. <source>Genome Biol</source> (<year>2014</year>) <volume>15</volume>:<fpage>R29</fpage>. doi: <pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r29</pub-id>
<pub-id pub-id-type="pmid">24485249</pub-id></mixed-citation>
              </ref>
              <ref id="B21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffrey</surname><given-names>KL</given-names></name><name><surname>Brummer</surname><given-names>T</given-names></name><name><surname>Rolph</surname><given-names>MS</given-names></name><name><surname>Liu</surname><given-names>SM</given-names></name><name><surname>Callejas</surname><given-names>NA</given-names></name><name><surname>Grumont</surname><given-names>RJ</given-names></name><etal/></person-group>. <article-title>Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1</article-title>. <source>Nat Immunol</source> (<year>2006</year>) <volume>7</volume>:<page-range>274–83</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni1310</pub-id>
</mixed-citation>
              </ref>
              <ref id="B22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elpek</surname><given-names>KG</given-names></name><name><surname>Cremasco</surname><given-names>V</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Harvey</surname><given-names>CJ</given-names></name><name><surname>Wucherpfennig</surname><given-names>KW</given-names></name><name><surname>Goldstein</surname><given-names>DR</given-names></name><etal/></person-group>. <article-title>The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells</article-title>. <source>Cancer Immunol Res</source> (<year>2014</year>) <volume>2</volume>:<page-range>655–67</page-range>. doi: <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-13-0209</pub-id>
</mixed-citation>
              </ref>
              <ref id="B23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Orr</surname><given-names>SS</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Khatri</surname><given-names>P</given-names></name><name><surname>Bodian</surname><given-names>DL</given-names></name><name><surname>Staedtler</surname><given-names>F</given-names></name><name><surname>Perry</surname><given-names>NM</given-names></name><etal/></person-group>. <article-title>Cell type–specific gene expression differences in complex tissues</article-title>. <source>Nat Methods</source> (<year>2010</year>) <volume>7</volume>:<page-range>287–9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.1439</pub-id>
</mixed-citation>
              </ref>
              <ref id="B24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Orr</surname><given-names>SS</given-names></name><name><surname>Gaujoux</surname><given-names>R</given-names></name></person-group>. <article-title>Computational deconvolution: Extracting cell type-specific information from heterogeneous samples</article-title>. <source>Curr Opin Immunol</source> (<year>2013</year>) <volume>25</volume>:<page-range>571–8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2013.09.015</pub-id>
</mixed-citation>
              </ref>
              <ref id="B25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>AN</given-names></name><name><surname>Watson</surname><given-names>CT</given-names></name><name><surname>Cohain</surname><given-names>AT</given-names></name><name><surname>Griffin</surname><given-names>RS</given-names></name><name><surname>Grishin</surname><given-names>A</given-names></name><name><surname>Wood</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children</article-title>. <source>J Allergy Clin Immunol</source> (<year>2020</year>) <volume>145</volume>:<page-range>1219–30</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2019.10.040</pub-id>
</mixed-citation>
              </ref>
              <ref id="B26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>VA</given-names></name><name><surname>Joesting</surname><given-names>JJ</given-names></name><name><surname>Freund</surname><given-names>GG</given-names></name></person-group>. <article-title>IL-1 receptor 2 (IL-1R2) and its role in immune regulation</article-title>. <source>Brain Behav Immun</source> (<year>2013</year>) <volume>32</volume>:<fpage>1</fpage>–<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbi.2012.11.006</pub-id>
<pub-id pub-id-type="pmid">23195532</pub-id></mixed-citation>
              </ref>
              <ref id="B27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerfoot</surname><given-names>SM</given-names></name><name><surname>Raharjo</surname><given-names>E</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name><name><surname>Kaur</surname><given-names>J</given-names></name><name><surname>Serirom</surname><given-names>S</given-names></name><name><surname>McCafferty</surname><given-names>D-M</given-names></name><etal/></person-group>. <article-title>Exclusive neutrophil recruitment with oncostatin m in a human system</article-title>. <source>Am J Pathol</source> (<year>2001</year>) <volume>159</volume>:<page-range>1531–9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0002-9440(10)62538-2</pub-id>
</mixed-citation>
              </ref>
              <ref id="B28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>T</given-names></name><name><surname>Kai</surname><given-names>H</given-names></name><name><surname>Shibata</surname><given-names>R</given-names></name><name><surname>Koga</surname><given-names>M</given-names></name><name><surname>Yoshimura</surname><given-names>A</given-names></name><name><surname>Imaizumi</surname><given-names>T</given-names></name></person-group>. <article-title>Oncostatin m, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2003</year>) <volume>23</volume>:<page-range>588–93</page-range>. doi: <pub-id pub-id-type="doi">10.1161/01.ATV.0000060891.31516.24</pub-id>
</mixed-citation>
              </ref>
              <ref id="B29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setiadi</surname><given-names>H</given-names></name><name><surname>Yago</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>McEver</surname><given-names>RP</given-names></name></person-group>. <article-title>Endothelial signaling by neutrophil-released oncostatin m enhances p-selectin–dependent inflammation and thrombosis</article-title>. <source>Blood Adv</source> (<year>2019</year>) <volume>3</volume>:<page-range>168–83</page-range>. doi: <pub-id pub-id-type="doi">10.1182/bloodadvances.2018026294</pub-id>
</mixed-citation>
              </ref>
              <ref id="B30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Keulen</surname><given-names>D</given-names></name><name><surname>Pouwer</surname><given-names>MG</given-names></name><name><surname>Pasterkamp</surname><given-names>G</given-names></name><name><surname>Van Gool</surname><given-names>AJ</given-names></name><name><surname>Gelpke</surname><given-names>MDS</given-names></name><name><surname>Princen</surname><given-names>HMG</given-names></name><etal/></person-group>. <article-title>Inflammatory cytokine oncostatinMinduces endothelial activation in macro- and microvascular endothelial cells and in APOE &amp;z.txt 3Leiden.CETP mice</article-title>. <source>PloS One</source> (<year>2018</year>) <volume>13</volume>:<fpage>1</fpage>–<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0204911</pub-id>
</mixed-citation>
              </ref>
              <ref id="B31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name></person-group>. <article-title>Activation-induced upregulation of MMP9 in mast cells is a positive feedback mediator for mast cell activation</article-title>. <source>Mol Med Rep</source> (<year>2017</year>) <volume>15</volume>:<page-range>1759–64</page-range>. doi: <pub-id pub-id-type="doi">10.3892/mmr.2017.6215</pub-id>
</mixed-citation>
              </ref>
              <ref id="B32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzer</surname><given-names>G</given-names></name><name><surname>Rosen</surname><given-names>N</given-names></name><name><surname>Plaschkes</surname><given-names>I</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Twik</surname><given-names>M</given-names></name><name><surname>Fishilevich</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The GeneCards suite: From gene data mining to disease genome sequence analyses</article-title>. <source>Curr Protoc Bioinforma</source> (<year>2016</year>) <volume>54</volume>:<fpage>1.30.1</fpage>–<lpage>1.30.33</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cpbi.5</pub-id>
</mixed-citation>
              </ref>
              <ref id="B33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>SGA</given-names></name><name><surname>Stone</surname><given-names>SF</given-names></name><name><surname>Fatovich</surname><given-names>DM</given-names></name><name><surname>Burrows</surname><given-names>SA</given-names></name><name><surname>Holdgate</surname><given-names>A</given-names></name><name><surname>Celenza</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Anaphylaxis: Clinical patterns, mediator release, and severity</article-title>. <source>J Allergy Clin Immunol</source> (<year>2013</year>) <volume>132</volume>:<page-range>1141–9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2013.06.015</pub-id>
</mixed-citation>
              </ref>
              <ref id="B34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korošec</surname><given-names>P</given-names></name><name><surname>Gibbs</surname><given-names>BF</given-names></name><name><surname>Rijavec</surname><given-names>M</given-names></name><name><surname>Custovic</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>PJ</given-names></name></person-group>. <article-title>Important and specific role for basophils in acute allergic reactions</article-title>. <source>Clin Exp Allergy</source> (<year>2018</year>) <volume>48</volume>:<page-range>502–12</page-range>. doi: <pub-id pub-id-type="doi">10.1111/cea.13117</pub-id>
</mixed-citation>
              </ref>
              <ref id="B35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauvreau</surname><given-names>GM</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Watson</surname><given-names>RM</given-names></name><name><surname>Irani</surname><given-names>A-MA</given-names></name><name><surname>Sschwartz</surname><given-names>LB</given-names></name><name><surname>O’Byrne</surname><given-names>PM</given-names></name></person-group>. <article-title>Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2000</year>) <volume>161</volume>:<page-range>1473–8</page-range>. doi: <pub-id pub-id-type="doi">10.1164/ajrccm.161.5.9908090</pub-id>
</mixed-citation>
              </ref>
              <ref id="B36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>CB</given-names></name><name><surname>Liu</surname><given-names>MC</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name><name><surname>Bochner</surname><given-names>BS</given-names></name><name><surname>Kagey-Sobotka</surname><given-names>A</given-names></name><name><surname>Lichtenstein</surname><given-names>LM</given-names></name></person-group>. <article-title>Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>1994</year>) <volume>10</volume>:<page-range>384–90</page-range>. doi: <pub-id pub-id-type="doi">10.1165/ajrcmb.10.4.7510984</pub-id>
</mixed-citation>
              </ref>
              <ref id="B37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iikura</surname><given-names>M</given-names></name><name><surname>Ebisawa</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Tachimoto</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Transendothelial migration of human basophils</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>:<page-range>5189–95</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.173.8.5189</pub-id>
</mixed-citation>
              </ref>
              <ref id="B38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jönsson</surname><given-names>F</given-names></name><name><surname>Mancardi</surname><given-names>D</given-names></name><name><surname>Kita</surname><given-names>Y</given-names></name><name><surname>Karasuyama</surname><given-names>H</given-names></name><name><surname>Iannascoli</surname><given-names>B</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Mouse and human neutrophils induce anaphylaxis</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<page-range>1484–96</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI45232</pub-id>
</mixed-citation>
              </ref>
              <ref id="B39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>A</given-names></name><name><surname>Bosio</surname><given-names>E</given-names></name><name><surname>Stone</surname><given-names>SF</given-names></name><name><surname>Fatovich</surname><given-names>DM</given-names></name><name><surname>Arendts</surname><given-names>G</given-names></name><name><surname>Nagree</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62L</article-title>. <source>Clin Exp Allergy</source> (<year>2017</year>) <volume>47</volume>:<page-range>361–70</page-range>. doi: <pub-id pub-id-type="doi">10.1111/cea.12868</pub-id>
</mixed-citation>
              </ref>
              <ref id="B40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>A</given-names></name><name><surname>Bosio</surname><given-names>E</given-names></name><name><surname>Stone</surname><given-names>SF</given-names></name><name><surname>Fatovich</surname><given-names>DM</given-names></name><name><surname>Arendts</surname><given-names>G</given-names></name><name><surname>MacDonald</surname><given-names>SPJ</given-names></name><etal/></person-group>. <article-title>Markers involved in innate immunity and neutrophil activation are elevated during acute human anaphylaxis: Validation of a microarray study</article-title>. <source>J Innate Immun</source> (<year>2019</year>) <volume>11</volume>:<fpage>63</fpage>–<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000492301</pub-id>
<pub-id pub-id-type="pmid">30189430</pub-id></mixed-citation>
              </ref>
              <ref id="B41">
                <label>41</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>BP</given-names></name><name><surname>Rothenberg</surname><given-names>ME</given-names></name></person-group>. <article-title>Inflammatory and effector Cells/Cell migration</article-title>. In: <source>Pediatric allergy: Principles and practice</source>, <edition>3rd ed</edition>. <publisher-name>Elsevier Inc</publisher-name> (<year>2015</year>). p. <fpage>41</fpage>–<lpage>53.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-323-29875-9.00005-7</pub-id>
</mixed-citation>
              </ref>
              <ref id="B42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bochner</surname><given-names>BS</given-names></name></person-group>. <article-title>Systemic activation of basophils and eosinophils: Markers and consequences</article-title>. <source>J Allergy Clin Immunol</source> (<year>2000</year>) <volume>106</volume>(<issue>5 SUPPL</issue>):<fpage>292</fpage>–<lpage>302</lpage>. doi: <pub-id pub-id-type="doi">10.1067/mai.2000.110164</pub-id>
</mixed-citation>
              </ref>
              <ref id="B43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Grant</surname><given-names>JA</given-names></name></person-group>. <article-title>Mediators of anaphylaxis</article-title>. <source>Immunol Allergy Clin North Am</source> (<year>2007</year>) <volume>27</volume>:<page-range>249–60</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.iac.2007.03.013</pub-id>
</mixed-citation>
              </ref>
              <ref id="B44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Undem</surname><given-names>BJ</given-names></name><name><surname>Taylor-Clark</surname><given-names>T</given-names></name></person-group>. <article-title>Mechanisms underlying the neuronal-based symptoms of allergy</article-title>. <source>J Allergy Clin Immunol</source> (<year>2014</year>) <volume>133</volume>:<page-range>1521–34</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2013.11.027</pub-id>
</mixed-citation>
              </ref>
              <ref id="B45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potenzieri</surname><given-names>C</given-names></name><name><surname>Meeker</surname><given-names>S</given-names></name><name><surname>Undem</surname><given-names>BJ</given-names></name></person-group>. <article-title>Activation of mouse bronchopulmonary c-fibres by serotonin and allergen-ovalbumin challenge</article-title>. <source>J Physiol</source> (<year>2012</year>) <volume>590</volume>:<page-range>5449–59</page-range>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2012.237115</pub-id>
</mixed-citation>
              </ref>
              <ref id="B46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreis</surname><given-names>ME</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Zittel</surname><given-names>TT</given-names></name><name><surname>Glatzle</surname><given-names>J</given-names></name><name><surname>Grundy</surname><given-names>D</given-names></name></person-group>. <article-title>Mediators of neuronal activation in the rat brainstem following intestinal anaphylaxis</article-title>. <source>Neurosci Lett</source> (<year>2000</year>) <volume>289</volume>:<page-range>45–8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0304-3940(00)01265-9</pub-id>
</mixed-citation>
              </ref>
              <ref id="B47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Bonham</surname><given-names>AC</given-names></name><name><surname>Joad</surname><given-names>JP</given-names></name><name><surname>Gershwin</surname><given-names>LJ</given-names></name><name><surname>Schelegle</surname><given-names>ES</given-names></name><name><surname>Plopper</surname><given-names>CG</given-names></name><etal/></person-group>. <article-title>Extended allergen exposure in asthmatic monkeys induces neuroplasticity in nucleus tractus solitarius</article-title>. <source>J Allergy Clin Immunol</source> (<year>2001</year>) <volume>108</volume>:<page-range>557–62</page-range>. doi: <pub-id pub-id-type="doi">10.1067/mai.2001.118132</pub-id>
</mixed-citation>
              </ref>
              <ref id="B48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname><given-names>Y</given-names></name><name><surname>Andoh</surname><given-names>T</given-names></name><name><surname>Shirakawa</surname><given-names>H</given-names></name><name><surname>Ishida</surname><given-names>H</given-names></name><name><surname>Hachiga</surname><given-names>T</given-names></name><name><surname>Kuraishi</surname><given-names>Y</given-names></name></person-group>. <article-title>Itch-related responses of dorsal horn neurons to cutaneous allergic stimulation in mice</article-title>. <source>Neuroreport</source> (<year>2009</year>) <volume>20</volume>:<page-range>478–81</page-range>. doi: <pub-id pub-id-type="doi">10.1097/WNR.0b013e3283293725</pub-id>
</mixed-citation>
              </ref>
              <ref id="B49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Kreis</surname><given-names>ME</given-names></name><name><surname>Eastwood</surname><given-names>C</given-names></name><name><surname>Kirkup</surname><given-names>AJ</given-names></name><name><surname>Humphrey</surname><given-names>PPA</given-names></name><name><surname>Grundy</surname><given-names>D</given-names></name></person-group>. <article-title>5-HT(3) and histamine H(1) receptors mediate afferent nerve sensitivity to intestinal anaphylaxis in rats</article-title>. <source>Gastroenterology</source> (<year>2000</year>) <volume>119</volume>:<page-range>1267–75</page-range>. doi: <pub-id pub-id-type="doi">10.1053/gast.2000.19461</pub-id>
</mixed-citation>
              </ref>
              <ref id="B50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>RL</given-names></name><name><surname>Wiggers</surname><given-names>M</given-names></name><name><surname>Snow</surname><given-names>DM</given-names></name><name><surname>Lee</surname><given-names>LY</given-names></name></person-group>. <article-title>Altered expression of TRPV1 and sensitivity to capsaicin in pulmonary myelinated afferents following chronic airway inflammation in the rat</article-title>. <source>J Physiol</source> (<year>2008</year>) <volume>586</volume>:<page-range>5771–86</page-range>. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2008.161042</pub-id>
</mixed-citation>
              </ref>
              <ref id="B51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinreich</surname><given-names>D</given-names></name><name><surname>Undem</surname><given-names>BJ</given-names></name></person-group>. <article-title>Immunological regulation of synaptic transmission in isolated guinea pig autonomic ganglia</article-title>. <source>J Clin Invest</source> (<year>1987</year>) <volume>79</volume>:<page-range>1529–32</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI112984</pub-id>
</mixed-citation>
              </ref>
              <ref id="B52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Undent</surname><given-names>BJ</given-names></name><name><surname>Myers</surname><given-names>AC</given-names></name><name><surname>Weinreich</surname><given-names>D</given-names></name></person-group>. <article-title>Antigen-induced modulation of autonomic and sensory neurons <italic>in vitro</italic>
</article-title>. <source>Int Arch Allergy Appl Immunol</source> (<year>1991</year>) <volume>94</volume>:<page-range>319–24</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000235394</pub-id>
</mixed-citation>
              </ref>
              <ref id="B53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schemann</surname><given-names>M</given-names></name><name><surname>Michel</surname><given-names>K</given-names></name><name><surname>Ceregrzyn</surname><given-names>M</given-names></name><name><surname>Zeller</surname><given-names>F</given-names></name><name><surname>Seidl</surname><given-names>S</given-names></name><name><surname>Bischoff</surname><given-names>SC</given-names></name></person-group>. <article-title>Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system</article-title>. <source>Neurogastroenterol Motil</source> (<year>2005</year>) <volume>17</volume>:<page-range>281–9</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2982.2004.00591.x</pub-id>
</mixed-citation>
              </ref>
              <ref id="B54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>HZ</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Neuroimmune interactions in guinea pig stomach and small intestine</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source> (<year>2003</year>) <volume>284</volume>:<page-range>G154–64</page-range>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00241.2002</pub-id>
</mixed-citation>
              </ref>
              <ref id="B55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogoz</surname><given-names>K</given-names></name><name><surname>Aresh</surname><given-names>B</given-names></name><name><surname>Freitag</surname><given-names>FB</given-names></name><name><surname>Pettersson</surname><given-names>H</given-names></name><name><surname>Magnúsdóttir</surname><given-names>EI</given-names></name><name><surname>Larsson Ingwall</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Identification of a neuronal receptor controlling anaphylaxis</article-title>. <source>Cell Rep</source> (<year>2016</year>) <volume>14</volume>:<page-range>370–9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.033</pub-id>
</mixed-citation>
              </ref>
              <ref id="B56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daynes</surname><given-names>RA</given-names></name><name><surname>Jones</surname><given-names>DC</given-names></name></person-group>. <article-title>Emerging roles of PPARs in inflammation and immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2002</year>) <volume>2</volume>:<page-range>748–59</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri912</pub-id>
</mixed-citation>
              </ref>
              <ref id="B57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Tontonoz</surname><given-names>P</given-names></name></person-group>. <article-title>Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors</article-title>. <source>Curr Opin Genet Dev</source> (<year>2008</year>) <volume>18</volume>:<page-range>461–7</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.gde.2008.07.016</pub-id>
</mixed-citation>
              </ref>
              <ref id="B58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Menn</surname><given-names>G</given-names></name><name><surname>Neels</surname><given-names>J</given-names></name></person-group>. <article-title>Regulation of immune cell function by PPARs and the connection with metabolic and neurodegenerative diseases</article-title>. <source>Int J Mol Sci</source> (<year>2018</year>) <volume>19</volume>:<fpage>1575</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms19061575</pub-id>
<pub-id pub-id-type="pmid">29799467</pub-id></mixed-citation>
              </ref>
              <ref id="B59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>SZ</given-names></name><name><surname>Usher</surname><given-names>MG</given-names></name><name><surname>Mortensen</surname><given-names>RM</given-names></name></person-group>. <article-title>Peroxisome proliferator-activated receptor-γ–mediated effects in the vasculature</article-title>. <source>Circ Res</source> (<year>2008</year>) <volume>102</volume>:<page-range>283–94</page-range>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.164384</pub-id>
</mixed-citation>
              </ref>
              <ref id="B60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>M</given-names></name><name><surname>Czimmerer</surname><given-names>Z</given-names></name><name><surname>Nagy</surname><given-names>L</given-names></name></person-group>. <article-title>The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology</article-title>. <source>J Allergy Clin Immunol</source> (<year>2013</year>) <volume>132</volume>:<page-range>264–86</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2013.05.044</pub-id>
</mixed-citation>
              </ref>
              <ref id="B61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez-Rodriguez</surname><given-names>T</given-names></name><name><surname>Garcia-Neuer</surname><given-names>M</given-names></name><name><surname>Alenazy</surname><given-names>LA</given-names></name><name><surname>Castells</surname><given-names>M</given-names></name></person-group>. <article-title>Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers</article-title>. <source>J Asthma Allergy</source> (<year>2018</year>) <volume>11</volume>:<page-range>121–42</page-range>. doi: <pub-id pub-id-type="doi">10.2147/JAA.S159411</pub-id>
</mixed-citation>
              </ref>
              <ref id="B62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenbarth</surname><given-names>SC</given-names></name><name><surname>Piggott</surname><given-names>DA</given-names></name><name><surname>Huleatt</surname><given-names>JW</given-names></name><name><surname>Visintin</surname><given-names>I</given-names></name><name><surname>Herrick</surname><given-names>CA</given-names></name><name><surname>Bottomly</surname><given-names>K</given-names></name></person-group>. <article-title>Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>196</volume>:<page-range>1645–51</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20021340</pub-id>
</mixed-citation>
              </ref>
              <ref id="B63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poza-Guedes</surname><given-names>P</given-names></name><name><surname>Barrios</surname><given-names>Y</given-names></name><name><surname>Fuentes</surname><given-names>V</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Sánchez-Machín</surname><given-names>I</given-names></name><name><surname>Alonso</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Downregulation of angiogenesis factors, VEGF and PDGF, after rapid IgE desensitisation and oral immunotherapy in children with food allergy</article-title>. <source>BioMed Res Int</source> (<year>2014</year>) <volume>2014</volume>:<fpage>372567</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2014/372567</pub-id>
<pub-id pub-id-type="pmid">24995287</pub-id></mixed-citation>
              </ref>
              <ref id="B64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname><given-names>DF</given-names></name><name><surname>Barrett</surname><given-names>NA</given-names></name><name><surname>Austen</surname><given-names>KF</given-names></name></person-group>. <article-title>Expression profiling of constitutive mast cells reveals a unique identity within the immune system</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<page-range>878–87</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3445</pub-id>
</mixed-citation>
              </ref>
              <ref id="B65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Harmacek</surname><given-names>L</given-names></name><name><surname>Long</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Lukin</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>The transcription factors GATA2 and microphthalmia-associated transcription factor regulate hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis</article-title>. <source>J Allergy Clin Immunol</source> (<year>2018</year>) <volume>142</volume>:<page-range>1173–84</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2017.10.043</pub-id>
</mixed-citation>
              </ref>
              <ref id="B66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>F</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Mdzomba</surname><given-names>JB</given-names></name><name><surname>Dumas</surname><given-names>A</given-names></name><name><surname>Pernet</surname><given-names>V</given-names></name><name><surname>Vallières</surname><given-names>L</given-names></name></person-group>. <article-title>Conditional deletions of hdc confirm roles of histamine in anaphylaxis and circadian activity but not in autoimmune encephalomyelitis</article-title>. <source>J Immunol</source> (<year>2021</year>) <volume>206</volume>:<page-range>2029–37</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.2000719</pub-id>
</mixed-citation>
              </ref>
              <ref id="B67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HN</given-names></name><name><surname>Ji</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>LN</given-names></name><name><surname>Xie</surname><given-names>CC</given-names></name><name><surname>Li</surname><given-names>WY</given-names></name><name><surname>Zhao</surname><given-names>ZF</given-names></name><etal/></person-group>. <article-title>Inhibition of c-fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1/Egr1/IL-4 axis</article-title>. <source>J Transl Med</source> (<year>2021</year>) <volume>19</volume>:<fpage>261</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-021-02932-0</pub-id>
<pub-id pub-id-type="pmid">34130714</pub-id></mixed-citation>
              </ref>
              <ref id="B68">
                <label>68</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name></person-group>. <article-title>Genetic variation at the interleukin-18 locus is associated with wheat-dependent exercise-induced anaphylaxis in the han Chinese population</article-title>. <source>Gene</source> (<year>2020</year>) <volume>737</volume>:<fpage>144462</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.gene.2020.144462</pub-id>
<pub-id pub-id-type="pmid">32045661</pub-id></mixed-citation>
              </ref>
              <ref id="B69">
                <label>69</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Béziat</surname><given-names>V</given-names></name><name><surname>Tavernier</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Ma</surname><given-names>CS</given-names></name><name><surname>Materna</surname><given-names>M</given-names></name><name><surname>Laurence</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome</article-title>. <source>J Exp Med</source> (<year>2020</year>) <volume>217</volume>:<elocation-id>e20191804</elocation-id>. doi: <pub-id pub-id-type="doi">10.1084/jem.20191804</pub-id>
<pub-id pub-id-type="pmid">32207811</pub-id></mixed-citation>
              </ref>
              <ref id="B70">
                <label>70</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capelle</surname><given-names>CM</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>N</given-names></name><name><surname>Baron</surname><given-names>A</given-names></name><name><surname>Grzyb</surname><given-names>K</given-names></name><name><surname>Arns</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Stress hormone signalling inhibits Th1 polarisation in a CD4 T-cell-intrinsic manner <italic>via</italic> mTORC1 and the circadian gene PER1</article-title>. <source>Immunology</source> (<year>2022</year>) <volume>165</volume>:<page-range>428–44</page-range>. doi: <pub-id pub-id-type="doi">10.1111/imm.13448</pub-id>
</mixed-citation>
              </ref>
              <ref id="B71">
                <label>71</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giavina-Bianchi</surname><given-names>P</given-names></name><name><surname>Gonçalves</surname><given-names>DG</given-names></name><name><surname>Zanandréa</surname><given-names>A</given-names></name><name><surname>Borges de Castro</surname><given-names>R</given-names></name><name><surname>Garro</surname><given-names>LS</given-names></name><name><surname>Kalil</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Anaphylaxis to quinolones in mastocytosis: Hypothesis on the mechanism</article-title>. <source>J Allergy Clin Immunol Pract</source> (<year>2019</year>) <volume>7</volume>:<page-range>2089–90</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaip.2019.01.059</pub-id>
</mixed-citation>
              </ref>
              <ref id="B72">
                <label>72</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiler</surname><given-names>CR</given-names></name></person-group>. <article-title>Mastocytosis, quinolones, MRGPRX2, and anaphylaxis</article-title>. <source>J Allergy Clin Immunol Pract</source> (<year>2019</year>) <volume>7</volume>:<page-range>2091–2</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.jaip.2019.02.015</pub-id>
</mixed-citation>
              </ref>
              <ref id="B73">
                <label>73</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelso</surname><given-names>JM</given-names></name></person-group>. <article-title>MRGPRX2 signaling and skin test results</article-title>. <source>J Allergy Clin Immunol Pract</source> (<year>2020</year>) <volume>8</volume>:<fpage>426</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaip.2019.09.038</pub-id>
</mixed-citation>
              </ref>
              <ref id="B74">
                <label>74</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arifuzzaman</surname><given-names>M</given-names></name><name><surname>Mobley</surname><given-names>YR</given-names></name><name><surname>Choi</surname><given-names>HW</given-names></name><name><surname>Bist</surname><given-names>P</given-names></name><name><surname>Salinas</surname><given-names>CA</given-names></name><name><surname>Brown</surname><given-names>ZD</given-names></name><etal/></person-group>. <article-title>MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection</article-title>. <source>Sci Adv</source> (<year>2019</year>) <volume>5</volume>:<elocation-id>eaav0216</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/sciadv.aav0216</pub-id>
<pub-id pub-id-type="pmid">30613778</pub-id></mixed-citation>
              </ref>
              <ref id="B75">
                <label>75</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Chompunud Na Ayudhya</surname><given-names>C</given-names></name><name><surname>Thapaliya</surname><given-names>M</given-names></name><name><surname>Deepak</surname><given-names>V</given-names></name><name><surname>Ali</surname><given-names>H</given-names></name></person-group>. <article-title>Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease</article-title>. <source>J Allergy Clin Immunol</source> (<year>2021</year>) <volume>148</volume>:<fpage>293</fpage>–<lpage>308</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2021.03.049</pub-id>
<pub-id pub-id-type="pmid">33957166</pub-id></mixed-citation>
              </ref>
              <ref id="B76">
                <label>76</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname><given-names>PL</given-names></name><name><surname>Sabaté-brescó</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Martín</surname><given-names>M</given-names></name><name><surname>Gastaminza</surname><given-names>G</given-names></name></person-group>. <article-title>The multifaceted mas-related g protein-coupled receptor member x2 in allergic diseases and beyond</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>:<fpage>1</fpage>–<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms22094421</pub-id>
</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
